Introduction
Breast cancer is the most common cancer in women worldwide. The U.S. incidence rate is stable but among the world's highest, and incidence is increasing globally (Forouzanfar et al., 2011) . The National Cancer Institute estimates that the cost of breast cancer care will reach $20.5 billion in the U.S. in 2020 (Mariotto et al., 2011) .
High penetrance inherited genes contribute to 5-10% of breast cancers (Campeau et al., 2008; Martin and Weber, 2000) , leaving a substantial portion of overall cases with potential for prevention. Modifiable risk factors include pharmaceutical hormones, lack of exercise, alcohol consumption, weight gain after menopause, nulliparity, late childbearing, and not lactating (Adami et al., 2008 ). In addition, mechanistic and rodent studies as well as epidemiology suggest that environmental chemicals likely play a role, and chemical links to breast cancer have been identified as a research priority (IBCERCC, 2013; IOM, 2012) .
We previously reviewed literature on environmental pollutants and breast cancer in 2007 and found the evidence generally supported positive associations with PAHs and polychlorinated biphenyls (PCBs) in combination with certain genetic polymorphisms, and for solvents and dioxins. Methodological problems included lack of highly exposed and unexposed populations for comparisons, inadequate exposure assessment, and study designs that did not capture exposure at the biologically relevant time, so that null results were uninformative. To update our assessment, in this paper we paired a summary of biological evidence with a review of epidemiological studies from the past 10 years. Our goal is to distill results from studies that use the strongest methods to evaluate hypotheses that accord with biological evidence. A limitation of this review is that we did not include several active areas of study relevant to breast cancer prevention: light at night (Gu et al., 2015; Hill et al., 2015; IARC 2010; Li et al., 2015; Sturgeon et al., 2014; Travis et al., 2016) , non-ionizing radiation (NTP, 2016a; West et al., 2013) , or metals (Byrne et al., 2013 ; NIEHS BCERP), because these topics are outside of our mechanistic area of expertise.
Known risk factors as models for environmental chemicals and breast cancer
Both laboratory and human evidence support a role for chemicals acting by (1) genotoxic action, (2) alteration of mammary gland development or hormone responsiveness, and (3) hormonal tumor promotion. These pathways, described briefly here, provide a helpful framework for considering epidemiological studies of chemically-induced breast cancer. Additional biological evidence for specific chemicals is incorporated in each section of this review.
Genotoxic agents damage genetic material in a cell, which may lead to cancer-causing mutations (Lee et al., 2013) . The progression from damaged DNA to cancer includes other processes, such as genomic instability, inflammation, and immune suppression (Hanahan and Weinberg, 2011) . Ionizing radiation, which increases breast cancer risk in both males and females (Land et al., 2003; Little and McElvenny, 2016) , is a model for the genotoxic action expected from classical carcinogens. Exposure to ionizing radiation most strongly increases breast cancer risk when it occurs in early life (e.g., before age 20 for atomic bomb survivors (Land et al., 2003) and medical radiation (Henderson et al., 2010) ). Mammary cells are thought to be most susceptible to damage from carcinogens during adolescence and before pregnancy, when the cells are rapidly proliferating and not yet fully differentiated (Russo and Russo, 2004) .
Second, exposure to endocrine disrupting chemicals (EDCs) in early life may alter breast development and increase adult susceptibility to breast cancer. For example, the synthetic estrogen diethylstilbestrol (DES) causes alterations in mammary gland structure and gene expression in rodents and was associated with breast cancer after age 40 in a U.S. cohort of women who were exposed in utero (Hoover et al., 2011) . Animal studies have found that perinatal exposure to DES can increase terminal end bud (TEB) and ductal formation during puberty (Fielden et al., 2002; Hovey et al., 2005; Rudel et al., 2011a) , suggesting a mechanism for increased breast cancer risk. Prenatal exposure to hormones and some chemicals that alter mammary development also increase mammary tumors when animals are challenged with a carcinogen during puberty (reviewed in Rudel et al., 2011a) . The prenatal period, puberty, and pregnancy, when cells proliferate and differentiate, are critical windows for exposures that alter mammary gland development, as reviewed in Rudel et al. (2011a) and Russo and Russo (2004) , although the relationship between mammary morphological changes and breast cancer risk is not well understood (Rudel et al., 2011a) .
Third, some EDCs may act closer to the time of diagnosis by promoting tumor growth through estrogen-or progesterone-mediated pathways or other hormonal responses (Lee et al., 2014; Rudel et al., 2014) . Increased breast cancer in women taking hormone replacement therapy (HRT) is a model for this pathway. The increase in risk persists for five years after stopping therapy and then diminishes (Roth et al., 2014) . Higher levels of estradiol are also a risk factor for postmenopausal breast cancer via a genomic response that increases cell proliferation or inhibits apoptosis, leading to tumor growth (Yager and Davidson, 2006) . Further, chemicals that activate enzymes involved in estradiol metabolism or synthesis, such as cytochrome p450 enzymes (CYPs), may contribute to breast cancer through downstream effects on endogenous estrogen, and progesterone is also important in controlling cell proliferation in the adult breast (Brisken et al., 2015) .
An additional consideration for biological hypotheses is that breast cancer is a heterogeneous disease. While the link between tumor subtype (e.g. hormone receptor (HR) positive vs negative) and prognosis/ responsiveness to treatment is well-established, differences in etiologic pathways underlying tumor subtypes and disease types (e.g. pre-vs postmenopausal) are not well understood.
Further, our review includes breast cancer incidence, mortality, and survival as outcomes. The mechanistic pathways outlined above are relevant to consider for incidence, the outcome of interest in the majority of the studies we reviewed. From a biological perspective, breast cancer mortality and survival are related to tumor aggressiveness and treatability. Because HR positive tumors have better survival due to hormone-targeted treatment, hormone-dependent tumor promotion may also be a relevant pathway for survival. However, the current lack of understanding of the etiological factors that lead to aggressive tumors, including HR negative tumors, limits hypotheses about relevant mechanisms for survival and mortality.
Methods

Study identification and selection
We searched PubMed for peer-reviewed articles published in English from June 2006 through June 2016 that reported on human studies of breast cancer and environmental pollutants. Searches included "breast cancer" in combination with terms for specific chemicals (excluding pharmaceuticals), chemical groups, and product classes, from the following sources: (1) terms used in Brody et al. (2007) , (2) three chemicals identified as mammary carcinogens by the National Toxicology Program (NTP) since 2007, (3) chemicals classified as potential mammary carcinogens with substantial population exposure by Rudel et al. (2014) , (4) chemicals identified as mammary gland developmental disruptors by Rudel et al. (2011a) , (5) "xenoestrogen burden," and (6) terms for consumer products (consumer products, flame retardant, hair dye, personal care products). We truncated certain terms (occupation, air pollution) to make the search more flexible; added MeSH terms (such as "hazardous waste") from relevant articles; and employed an "etiology filter" (Harvey Cushing/John Jay Whitney Medical Library). Search terms are listed in Table S1 .
We screened abstracts for relevance in two phases. Abstracts were first screened by SC (abstracts 2006 SC (abstracts -2010 or KR (abstracts 2010 KR (abstracts -2016 , using inclusion and exclusion criteria summarized in Table 1 . To check the accuracy of screening, in June-July 2016, a third reviewer (SF) repeated the search, screened a portion of identified abstracts, and recorded decisions in Abstrackr BETA (Abstrackr) . This program generates an algorithm based on the user's screening decisions to predict the relevance of remaining abstracts (Wallace et al., 2012) . After SF screened 987 of the 3133 unique abstracts, identifying 209 articles for full-text review, Abstrackr predicted that none of the rest were relevant. Conflicts between decisions in the first and second round of screening were resolved by a fourth reviewer (JU). Nine additional articles were identified from related PubMed searches outside the systematic search. Of the 218 articles identified by abstract screening, 158 remained eligible after full-text review. Table 1 indicates the number of articles excluded based on each criterion during full-text review.
Biological evidence
We used International Agency for Research on Cancer (IARC) monographs, the NTP Report on Carcinogens, and published literature to evaluate breast-cancer-related biological activity of chemicals. We summarized chemical uses, human exposure, and laboratory evidence of mammary carcinogenicity, developmental disruption, and other actions that could contribute to breast cancer.
Data extraction and synthesis
To critically review eligible articles, we evaluated inclusion criteria for participants, appropriateness of controls and reference groups, exposure assessment, control for confounding, and the strength of associations. We focused on the validity and precision of exposure assessment, timing and duration of exposure, length of follow-up after exposure to allow for disease latency, and whether the range of studied exposures provided a strong contrast. In recent years, the recommended approach for identifying confounders has shifted toward an emphasis on using causal diagrams to encode a priori knowledge/hypotheses; these diagrams are then used to assess relationships between measured and unmeasured variables and determine which variables should be adjusted or otherwise accounted for in the analysis (Greenland et al., 1999; Hernan et al., 2002) . For example, causal diagrams can help identify variables on the causal pathway, which should not be considered confounders. In our previous review, we discussed the potential for known breast cancer risk factors to mediate associations between chemical exposures and breast cancer . In the current review, studies of female breast cancer were considered minimally controlled for confounding if they included age and reproductive history as potential confounders. Our assessment was based on confounders considered at any point in the analysis, not just those included in the final adjusted effect estimate. We also noted whether studies considered body size, physical activity, HRT/oral contraceptives, alcohol use and/or family history, and indicated any relevant findings from these analyses in supplemental tables.
In extracting results, we relied on adjusted relative risks if they were reported, and prioritized effect estimates that (1) captured a hypothesized biologically relevant window or gene-environment interaction, (2) allowed evaluation of a dose-response (rather than ever/never exposure), and/or (3) considered occupational exposure to specific agents with hypothesized breast cancer mechanisms (e.g. rodent mammary carcinogens). We also extracted data on analyses that stratified by tumor subtype or menopausal status to assess etiologic heterogeneity. For studies that we considered useful for hypothesis generation (e.g. ecological studies, job title studies), we focused on positive findings. Our assessments of each article, including comments about potential bias and about biologically relevant features of exposure (timing, gene interaction) and disease (menopausal status, tumor subtype) captured by the study, are shown in Supplemental Tables S2-S11 and in our freely accessible online database, available at URL: http:// sciencereview.silentspring.org.
For each exposure group, we discussed consistency of findings for studies that considered relevant biological features. Unless otherwise specified, we limited our synthesis of results to studies that were at least minimally controlled for confounding, as described above (93 of 158 studies we reviewed) and occupational cohort studies with an internal comparison (3 additional studies). These occupational cohorts are less vulnerable to confounding, because we expect the comparison group to be similar in breast cancer risk factors, such as socioeconomic status, education, and access to health care. We also discussed, with qualification, three studies that did not meet the above criteria but captured a unique exposure or exposure scenario (Ghisari et al., 2014; Sathiakumar and Delzell, 2009; Sung et al., 2007) . We drew conclusions about the overall strength of evidence from studies with at least minimal control for confounding, adequate exposure assessment, and no identified major sources of bias.
Results & discussion
Since 2006, we identified 151 new reports and 7 meta-analyses of epidemiologic studies of environmental pollutants and breast cancer. Study results concerning diet, tobacco smoke, shift work, pharmaceuticals, metals, or natural disasters. 14 5
Studies of occupations (including work in offices, schools, and stores) for which existing data do not support a reasonable inference about exposure to a specific chemical or mixture that has been characterized and hypothesized to affect breast cancer. 6 6 Studies of occupations with likely exposure to ionizing radiation for which the environmental pollutant exposure was not assessed independently of ionizing radiation.
7
Occupational studies in which the exposure was defined as work in a nonindustrial occupation and there was no control for confounding or evidence that the exposed and comparison groups were similar for reproductive risk factors.
8
Occupational studies in which the exposed group was predominantly exposed < 1 year. 0 9
Studies of female breast cancer with five or fewer exposed women. 0 10
Studies of male breast cancer with < 1 observed or expected case. 0 11. Meta-analyses that combined studies with non-comparable exposure measures. 1
Fifty-two studies used geographic location to estimate exposure, some employing detailed residential histories and individual-level exposure models. Thirty-nine used biological measures, and the rest considered employment records or self-report of occupational or other exposures. The persistent bioaccumulative organochlorines DDT/dichlorodiphenyldichloroethylene (DDE) and PCBs remained frequentlystudied, though nearly all studies still relied on biological measurements collected at or after diagnosis, which may capture exposures relevant to tumor promotion but not earlier stages of breast cancer development. Reports on air pollution increased, constituting nearly one-third of the studies we reviewed. Gene-environment interactions were considered in 18 reports, mostly studies of PAHs from the Long Island Breast Cancer Study Project (LIBCSP). Few studies considered current pesticides or consumer product chemicals. New studies of occupational exposures to organic solvents improved on earlier methods by collecting detailed job histories and employing industrial hygiene assessments to estimate cumulative lifetime exposure.
Appropriateness of comparison groups remains a concern in occupational studies, with many studies using the general population as a comparison group or including people employed in white collar jobs at the same facility, although many jobs with relevant chemical exposures are held by blue-collar workers. Historically, breast cancer incidence has decreased with declining socioeconomic status (SES), as measured by various markers including education, occupational class (e.g. skilled vs unskilled, white-vs blue-collar), and income (Faggiano et al., 1997) . Further, the healthy worker effect may be a concern, because blue collar work tends to be more physically active (Brighenti-Zogg et al., 2016; Steele and Mummery, 2003) . A recent analysis among women with a family history of breast cancer found reduced breast cancer risk among women who were "active" in the majority (> 75%) of their lifetime work compared to those who were not (Ekenga et al., 2015b; Lahmann et al., 2007) . When the comparison group is at a higher risk for breast cancer, effect estimates for an exposure can be biased.
The most informative studies match study design with mechanistic evidence and biological hypotheses. Fig. 1 serves as a framework for this review by summarizing hypothesized biological actions and relevant windows of exposure for which there is experimental evidence of mammary gland effects for chemicals in each group. Fig. 1 also shows the distribution of studies (excluding meta-analyses) by the exposure window captured; nearly two thirds of analyses -including 44% of those that were at least minimally controlled for confounding -were not designed to capture exposure during a specific window of breast development or before menopause, limiting their potential to identify effects via some of the hypothesized biological pathways. Tables 3A-3D summarize findings for the studies that minimally controlled for confounding and also included biologically relevant features: exposures in early life, pre-vs. postmenopausal diagnosis, gene variants, and analysis by tumor type. These tables are organized as follows (3A: persistent EDCs and unspecified pesticides, 3B: PAH biomarkers and air pollution, 3C: consumer product chemicals and drinking water, and 3D: organic solvents and occupations/occupational exposures).
Two cohorts in particular provide unique opportunities to examine relevant periods of exposure. In the Child Health and Development Studies (CHDS), blood samples collected during pregnancy or shortly after childbirth in the 1950s and 1960s allowed evaluation of breast cancer risks associated with OCP and PCB exposures in early life, including in utero, during a period of high exposures (Cohn et al., 2007 (Cohn et al., , 2012 (Cohn et al., , 2015 . Key findings from this cohort are highlighted in Fig. 2 and Fig. 1 . Few breast cancer epidemiology studies 2006-2016 assessed exposure during a biologically relevant window; the majority did not specify the timing of exposure. Biological Activity: Check marks indicate that there is experimental evidence for this type of activity for a chemical or chemicals in this group. Lack of a check mark does not indicate null findings. NA means not applicable. G (Genotoxic): Genotoxic chemicals are expected to affect breast cancer diagnosis after 10-20 years latency and are more potent while the breast is developing. RMC (Rodent mammary carcinogens): Rodent MCs induce tumors when given to adult animals. EA (Endocrine Active): Diverse endocrine active chemicals alter mammary gland discussed in Sections 3.1.2 and 3.1.3, including positive associations between DDT components and later breast cancer in both mothers and daughters and for PCB congeners and breast cancer in the mothers (results not reported for the daughters). More recently, the Danish National Birth Cohort (DNBC) collected blood samples from women during early pregnancy between 1996 and, through 2010, found elevated breast cancer risk with the highest blood PFOSA levels (Section 3.4.5).
Other innovations included studies that investigated mixtures of chemicals using an integrated measure of activity from known and unknown estrogenic substances in blood (Bonefeld-Jorgensen et al., 2011; Pastor-Barriuso et al., 2016) and the comprehensive prospective exposure assessment for the Sister Study. The Sister Study enrolled women between 2003 and 2009 who had a sister with breast cancer but were themselves breast cancer-free and conducted detailed interviews at baseline, including questions about occupational and residential histories, proximity to traffic or agriculture and use of certain products, and whether those exposures occurred during specific critical windows (NIEHS).
We summarized results by chemical exposure type, focusing on the most informative studies, as described in Section 2.3. Biological mechanisms are explained in most detail when they are first introduced, and the order for the chemical groupings is designed to progressively build on this information. Table 2 shows how we organized the literature we reviewed. Studies with more than one exposure category (e.g., PCBs and OCPs) are reviewed in both relevant sections of the paper, and results for specific chemicals are included in relevant chemical sections (e.g., occupational PCB exposure is covered in PCBs instead of occupation).
Persistent endocrine disrupting chemicals
We consider dioxins, PCBs and OCPs together as persistent EDCs, although they have distinct activity profiles. These chemicals are not expected to act as classical carcinogens in the breast because they have low genotoxic activity and do not produce mammary tumors in standard experiments in adult rodents (Rudel et al., 2011a . However, persistent EDCs may contribute to breast cancer by altering mammary gland development or hormone responsiveness, especially with exposures in early life, as in the example of DES explained earlier. They may also promote tumor growth through estrogen-or progesterone-mediated pathways, like HRT (Lee et al., 2014; Rudel et al., 2014) . Some persistent EDCs, like dioxins, bind to the aryl hydrocarbon receptor (AhR), a nuclear transcription factor that influences gene expression, enzyme metabolism, and hormone signaling pathways (NTP, 2016b) . Persistent EDCs bioaccumulate in fat, and studies with biological samples typically measure levels in blood (serum or plasma), though a few use adipose tissue from the breast or elsewhere. When non-fasting blood samples are used, most analyses consider lipid content, but methods vary. The most common method is to standardize by dividing chemical mass by mass of lipid in the sample; another approach includes lipid measures as a covariate in regression models (see "exposure measure" column in supplemental tables for lipid control measure used in each study). Dioxins, PCBs, and OCPs each represent a mixture of related chemicals that vary in biological activity and metabolic half-life. Concentrations in blood can reflect the source of exposure, time since exposure, and individual variation in metabolism.
Dioxins
Dioxins are a mixture of chemicals produced from combustion and industrial processes involving chlorine, including production of pesticides, bleached paper, and polyvinyl chloride (United Nations Environment Programme, 2005) . Incineration of medical and municipal waste and sewage sludge and backyard burning of trash are the most significant sources in the environment (National Center for Environmental Assessment Office of Research and Development, 2006) . Most human exposure is from fat in contaminated food, including milk, eggs, fish, and meat. Epidemiologic studies generally assess dioxin exposure based on geographical location in relation to a known point source or in an area where dioxin was measured in soil; other methods include job exposure matrices (JEMs) and rarely, in biological samples.
3.1.1.1. Biological evidence. 2,3,7,8-Tetrachlorodibenzo-para-dioxin (TCDD) is the most potent dioxin. IARC classified TCDD as carcinogenic to humans based on risk of lung cancer, soft-tissue sarcoma, non-Hodgkin's lymphoma, and all cancers combined in occupationally exposed populations (IARC 2012b). TCDD is not genotoxic; its carcinogenicity is thought to result from oxidative damage and tumor promotion through pathways that interrupt apoptosis (Knerr and Schrenk, 2006; Tsuchiya et al., 2005) , which are likely related to activation of the AhR (NTP, 2016b) . Dioxins interfere with estrogen signaling through ER-AhR cross talk (Boverhof et al., 2006; Matthews and Gustafsson, 2006) . Rodent studies show contrary effects at different life stages. Mammary gland development was altered in studies of both pubertal (Brown and Lamartiniere, 1995) and in utero (Brown et al., 1998) exposure; after in utero exposure, a carcinogen challenge showed increased susceptibility (Brown et al., 1998) . In contrast, adult exposure reduced mammary tumors and suppressed metastasis in mice, presumably due to anti-estrogenic activity via ERAhR crosstalk (Boverhof et al., 2006; Kociba et al., 1978; Matthews and Gustafsson, 2006; Wang et al., 2011) .
3.1.1.2. Epidemiologic studies. Of eight new studies of dioxins and breast cancer, two reports following women after the 1976 industrial accident in Seveso, Italy, are of particular interest because they evaluated women with exposure specifically to TCDD, rather than a mixture, and compare them with an unexposed group. The Seveso Women's Health Study (SWHS) measured TCDD in blood samples from women aged zero to 40 and living in the most-contaminated areas at the time of the accident. Most of the samples were collected within a year after the accident, but 9% were collected 2-21 years later. The elimination half-life of TCDD is estimated at 5-10 years in adults but varies with age, with evidence of much shorter half-lives in infants and children (Kerger et al., 2006) , so kinetic models were used to estimate (Brauner et al., 2014) ↔ for CYP1B1 or COMT gene variants and PCB groupings in DDCH study (premenopausal cancers not studied) (Brauner et al., 2014) MS: Pre + post TT: ER+/-, PR+/-, p53+/-, low/moderate/high expression of HER2/neu ↔ for total PCBs in Women's CARE Study (Gatto et al., 2007) TT: ER-/PR-& ER+/PR-↓ for increasing total PCBs (Itoh et al., 2009) TT: ER+, PR+, HER2+, ECadherin+, p53+
↑ for some but not all tumor types for different PCB congeners (Arrebola et al., 2016) OCPs MS: Premenopausal TT: Non-specific ↑ for p,p'-DDT, ↓ for o,p'-DDT at pregnancy among CHDS mothers < age 14 in 1945 (postmenopausal cancers not studied) (Cohn et al., 2007) ↔ for seeing fogger truck < 1972 at age < 20 or age < 14 in LIBCSP (White et al., 2013 )↑ for in utero p,p'-DDT and o,p'-DDT (stronger for o,p'-DDT) in CHDS (postmenopausal cancers not studied) (Cohn et al., 2015) and for ever been fogged or sprayed as child & for ever been fogged or sprayed and age 0-18 at time of peak DDT use in Sister Study (Niehoff et al., 2016) Some ↑ for different OCPs (Iwasaki et al., 2008 )↓ for some OCPs (Itoh et al., 2009 ) ↑ for DDE exposure in meta-analysis (Ingber et al., 2013) and for total xenoestrogen burden (Pastor-Barriuso et al., 2016) TT: HER2+ ↑ for in utero o,p'-DDT in CHDS daughters age < 50 (postmenopausal cancers not studied) (Cohn et al., 2015) MS: Postmenopausal TT: Non-specific ↔ for seeing fogger truck < 1972 at age < 20 or age < 14 in LIBCSP (White et al., 2013 )↑ for ever been fogged or sprayed as child and for ever fogged or sprayed and age 0-18 at time of peak DDT use in Sister Study (Niehoff et al., 2016) Some ↑ for different OCPs (Iwasaki et al., 2008 (Parada et al., 2016b) MS: Pre + post TT: Non-specific ↔ for seeing fogger truck < 1972 at age < 20 or age < 14 in LIBCSP (White et al., 2013) TT: ER+/PR+ ↑ for seeing fogger truck < age 14, < age 20, and at any age ≤1972 in LIBCSP (White et al., 2013) ↔ for ever been fogged or sprayed as child;
↑ ever fogged or sprayed and age 0-18 at time of peak DDT use in Sister Study (Niehoff et al., 2016) (Gatto et al., 2007) TT: ER+, PR+, HER2+, ECadherin+, p53+
Some ↑ and ↓ for HCB; ↑risk for p,p-DDE & some tumor subtypes (Arrebola et al., 2016) Unspecified pesticides and non-OCPS MS: Premenopausal TT: Non-specific ↑ for some residential farm exposures < age 18 in Sister Study (Niehoff et al., 2016) ↑ for occupational pesticide use in Sister Study (Ekenga et al., 2015a ) Some ↑ for different OP pesticides in AHS (Lerro et al., 2015) MS: Postmenopausal TT: Non-specific ↑ for some residential farm exposures < age 18 in Sister Study (Niehoff et al., 2016) Some ↑ for different OP pesticides in AHS (Lerro et al., 2015) MS: Pre + post TT: Non-specific ↑ for observed pesticide spray drift (Niehoff et al., 2016) TT: ER-/PRSome ↑ for various OP pesticides in AHS (Lerro et al., 2015) TT: HR+, HR-↑ for occupational pesticide use in Sister Study (Ekenga et al., 2015a) Breast development occurs in utero, during puberty, and in early adulthood through the first pregnancy.
K.M. Rodgers et al. Environmental Research 160 (2018) 152-182 (Sagiv et al., 2009) MS: Pre + post TT: Non-specific ↑ for PAH-DNA adducts and IGHMBP2 polymorphism (Shen et al., 2006) ; apoptosis-related polymorphisms (Crew et al., 2007a) ; some NER genes (Crew et al., 2007b; Shen et al., 2008) , any 3 GST polymorphisms (McCarty et al., 2009) ; & with different gene promoter methylation status (White et al., 2015) . Limited evidence of ↑ for PAH-DNA adducts and TP53
polymorphisms & mutations (Gaudet et al., 2008; Mordukhovich et al., 2010) TT: ER+/PR+, ER-/ PR-↑ mortality (worse survival) for PAH-DNA adducts among cases (Sagiv et al., 2009) TT: ER+/PR+, ER-/PR +, ER+/PR-& ER-/PR-↑ for DNA-PAH adducts and different gene promoter methylation status (White et al., 2015) Air pollution
MS:
Premenopausal TT: Non-specific ↑ for residential exposure to traffic in early life (Nie et al., 2007) ↑ for some MGCs in ambient air at residence in CTS ; for NO 2 exposure at residence, particularly when considering long-term residential history (Hystad et al., 2015) ; for closer residential proximity to large roads in NHSII (Hart et al., 2016) ;
for traffic exposure in LIBCSP (Mordukhovich et al., 2016b) ; and for occupational diesel and gasoline exhaust in BCEES (Rai et al., 2016) Some ↑ for residential proximity and residential duration to different polluting industries (Pan et al. 2011 ) ↔ for PM 10 , PM 2.5 , PM 2.5-10 at residence in NHSII (Hart et al., 2016) MS: Postmenopausal TT: Non-specific ↑ for residential exposure to traffic in early life (Nie et al., 2007) and for occupational PAH (any and petroleum-related) exposure < age 36 (premenopausal cancers not studied) ↑ for occupational PAH exposure ; for NO 2 exposure at residence > 10 years before diagnosis (Crouse et al., 2010) (Hystad et al., 2015) ; for some MGCs in ambient air at residence in CTS ; and for closer residential proximity to large roads in NHSII (Hart et al., 2016 ) Some ↑ for residential proximity and duration to different polluting industries (Pan et al., 2011) ↔ for proximity to major street or high traffic on nearby street (Raaschou-Nielsen et al., 2011) ; occupational diesel and gasoline exhaust in BCEES (Rai et al., 2016) ; and for traffic exposure in LIBCSP (Mordukhovich et al., 2016b) ↔ for PM 10 , PM 2.5-10 and ↓ for PM 2.5 at residence in NHSII (Hart et al., 2016) (continued on next page) K.M. Rodgers et al. Environmental Research 160 (2018) 152-182 ) ↑ for lifetime occupational PAH (any and petroleumrelated) exposure (premenopausal cancers not studied) MS: Pre + post TT: Non-specific ↑ for some indoor PAH exposure < age 20 in LIBCSP (White et al., 2014) ↑ w/ GST variants and some indoor PAH exposure in LIBCSP (White et al., 2014) ; w/ NER polymorphisms (Mordukhovich et al., 2016a ) and p53-mutation and residential traffic exposure in LIBCSP (Mordukhovich et al., 2016b) ↔ for occupational diesel or gasoline exposures before first childbirth (Rai et al., 2016) TT: ER+/PR+ ↑ for some MGCs and for some EDCs (R Liu et al., 2015) in ambient air at residence in CTS; for closer residential proximity to large roads & for PM 2.5-10 at residence in NHSII (Hart et al., 2016) ; and for NO 2 exposure at residence (Reding et al., 2015) ↔ for residential traffic exposure in LIBCSP (Mordukhovich et al., 2016b ) and for PM 10 & PM 2.5 in NHSII (Hart et al., 2016) TT: ER-/PR-↑ for some MGCs in ambient air at residence in CTS ; for some EDCs in ambient air at residence in CTS (R Liu et al., 2015) ; for closer residential proximity to large roads in NHSII (Hart et al., 2016) ; and for residential traffic exposure in LIBCSP (Mordukhovich et al., 2016b) ↔ for NO 2 exposure at residence (Reding et al., 2015) and for PM This table summarizes results from analyses that captured relevant exposure and disease features suggested by toxicological and biological evidence of genotoxicity, endocrine disruption, tumor promotion, or disruption of mammary gland development. This table includes studies that at least minimally controlled for confounding (at least age and reproductive history). The studies also reported other analyses. Additional details about the studies, including exposure measures and study population, are found in supplemental tables S6-S7, organized by chemical or exposures investigated.
a Breast development occurs in utero, during puberty, and in early adulthood through the first pregnancy.
K.M. Rodgers et al. Environmental Research 160 (2018) 152-182
Table 3C Breast cancer findings for consumer product chemicals and drinking water in epidemiological studies with designs that considered key features from experimental evidence: windows of susceptibility, genetic susceptibility, or heterogeneity of disease. Exposure This table summarizes results from analyses that captured relevant exposure and disease features suggested by toxicological and biological evidence of genotoxicity, endocrine disruption, tumor promotion, or disruption of mammary gland development. This table includes studies that at least minimally controlled for confounding (at least age and reproductive history). The studies also reported other analyses. Additional details about the studies, including exposure measures and study population, are found in supplemental tables S8-S9, organized by chemical or exposures investigated.
b
Chemical has short half-life in the body, and exposure estimate relied on a single measurement, which may not be representative. ↑ for occupational exposure to total solvents, but not benzene specifically (Peplonska et al., 2010) ; for several types of occupational solvent exposures in BCEES (Glass et al., 2015) ; & for occupational solvent exposure in Sister Study (Ekenga et al., 2015a) MS: Postmenopausal TT: Non-specific ↑ for occupational solvent exposure < age 36 (premenopausal cancers not studied) ) ↑ for lifetime occupational solvent exposure (premenopausal cancers not studied) ; for occupational exposure to total solvents, but not benzene specifically (Peplonska et al., 2010) ; & for several types of occupational solvent exposures in BCEES (Glass et al., 2015) ↔ for occupational solvent exposure in Sister Study (Ekenga et al., 2015a) TT: ER+/PR+ & ER +/PR-↑ for occupational solvent exposure < age 36 (premenopausal cancers not studied) ) ↑ for lifetime occupational solvent exposure (premenopausal cancers not studied) TT: ER-/PR-↔ for occupational solvent exposure < age 36 (premenopausal cancers not studied) ) ↑ for lifetime occupational solvent exposure (premenopausal cancers not studied) MS: Pre + post TT: Non-specific ↑ for occupational solvent exposure before first childbirth and < age 20 in Sister Study (Ekenga et al., 2014) and for some occupational solvent exposures in BCEES (Glass et al., 2015) TT: ER+/PR+ ↔ for occupational solvent exposure (Peplonska et al., 2010) TT: ER+/PR-, ER-/PRand ER-/PR+ ↑ for occupational solvent exposure (Peplonska et al., 2010) TT: ER+ ↑ for occupational solvent exposure before first childbirth and < age 20 in Sister Study (Ekenga et al., 2014 ) ↑ for several types of occupational solvent exposures in BCEES (Glass et al., 2015) & for occupational solvent exposure in Sister Study (Ekenga et al., 2014) TT: ER-↔ for occupational solvent exposure before first childbirth, ↑ for exposure < age 20 in Sister Study (Ekenga et al., 2014 ) ↑ for several types of occupational solvent exposures in BCEES (Glass et al., 2015) ↔ for occupational solvent exposure in Sister Study (Ekenga et al., 2014) TT: HR+ ↑ for occupational solvent exposure in Sister Study (Ekenga et al., 2015a) TT: HR-↑ for occupational solvent exposure in Sister Study (Ekenga et al., 2015a) Occupation
MS: Premenopausal
TT: Non-specific ↑ for several occupations (Brophy et al., 2012 ) (Peplonska et al., 2007) and for occupational exposures to some specific agents in Sister Study (Ekenga et al., 2015a) MS: Postmenopausal TT: Non-specific ↑ for several occupational exposures < age 36 (premenopausal cancers not studied) ↔ for postmenopausal cancer (Olesen et al., 2008 ) & ↑ for mortality (worse survival) (Olsen et al., 2012) with acrylamide adducts in DDCH (premenopausal cancers were not studied)
↑ for occupational exposures to some specific agents (premenopausal cancers not studied) and in the Sister Study (Ekenga et al., 2015a) ↑ for several occupations (Brophy et al., 2012 ) (Peplonska et al., 2007) TT: ER+ ↑ for acrylamide adducts in DDCH, both incidence (Olesen et al., 2008 ) & mortality (worse survival) (Olsen et al., 2012 ) (premenopausal cancers were not studied)
TT: ER-↔ for acrylamide adducts in DDCH, incidence (Olesen et al., 2008) (premenopausal cancers were not studied)
TT: ER+/PR+ & ER +/PR-↑ for different occupational exposures < age 36 (premenopausal cancers not studied) ) ↑ for different lifetime occupational exposures (premenopausal cancers not studied) MS: Pre + post Rodgers et al. Environmental Research 160 (2018) 152-182 1976 levels for the later samples (Warner et al., 2011) ; while this approach appears valid, it would have been useful if the authors had presented data comparing those with modeled and measured TCDD (e.g. distribution of risk factors and TCDD levels). Over 32 years of follow-up, breast cancer risk increased for each 10-fold increase of lipid-standardized TCDD in serum (HR 1.44; 95% CI 0.89-2.33) (Warner et al., 2011) . Risk was increased for 0-10 years (unadjusted HR 2.91; 95% CI 0.90-9.44) and 11-20 years (unadjusted HR 2.23; 95% CI 1.09-4.56) but not for 21-32 years of follow-up (unatabledjusted HR 1.06; 95% CI 0.58-1.93). The women exposed earliest in life are now 40 and the average age of the cohort is 51, so future analysis will reveal whether the period of increased risk has passed. Another study of a larger 'residential' cohort of Seveso women (Pesatori et al., 2009 ) did not meet our criteria for discussion but is reviewed in Table S2 .
Of the remaining studies, one found increased breast cancer incidence in European men with higher PCB and dioxin exposure based on job questionnaires (Villeneuve et al., 2010) , while the rest did not meet our criteria for discussion. See Table S2 for our assessments and summaries from these studies.
Polychlorinated biphenyls
PCBs, a group of 209 aromatic compounds (congeners) with various chlorine substitution patterns, were used globally in electrical equipment and other industrial applications from the 1920s until the late 1970s -early 1980s (IARC 2016b). They persist in fatty foods like fish and in indoor air and dust contaminated with caulk, building materials, or floor finishes containing PCBs (Rudel et al., 2008) . PCBs are fat soluble and generally have half-lives from 3 to 15 years in humans, with higher chlorinated congeners having longer half-lives (IARC, 2016b) . The mix of congeners in blood reflects the exposure source, for example fish versus occupational or indoor air exposure (Freels et al., 2007; Rudel et al., 2008) .
3.1.2.1. Biological evidence. IARC classifies PCBs as carcinogenic to humans based on evidence of malignant melanoma and positive associations with breast cancer and non-Hodgkin lymphoma (IARC, 2016b) . Some congeners (PCB-126 and PCB-118) and highly chlorinated commercial mixtures (Araclor 1260, Araclor 1254, and Kanechlor 500) exhibit dioxin-like activity and bind to the AhR, while other congeners, or their metabolites, have various cancer-related activity, including tumor promotion, estrogen activity, and CYP TT: Non-specific ↑ for some occupations in early life windows (Brophy et al., 2012) TT: ER+ ↑ for ≥ 1 year of occupational aromatic/heterocyclic amine exposure (Rabstein et al., 2010) TT: PR+ ↑ for ≥ 1 year of occupational aromatic/heterocyclic amine exposure (Rabstein et al., 2010) TT: ER-↑ for several occupations (Brophy et al., 2012) TT: ER+/PR+ and ER +/PR-↑ for several occupations (Brophy et al., 2012) TT: HR+ and HR-↑ for occupational exposure to some specific agents in Sister Study (Ekenga et al., 2015a) BCEES = Breast Cancer Environment and Employment Study, DDCH = Danish Diet Cancer and Health study.
TT = tumor type, MS = menopausal status ↑ = statistically significant elevated risk or OR > 1.1; ↓ = statistically significant decreased risk; ↔ = no increased or significantly decreased risks.
This table summarizes from analyses that captured relevant exposure and disease features suggested by toxicological and biological evidence of genotoxicity, endocrine disruption, tumor promotion, or disruption of mammary gland development. This table includes studies that at least minimally controlled for confounding (at least age and reproductive history). The studies also reported other analyses. Additional details about the studies, including exposure measures and study population, are found in supplemental tables S10-S11, organized by chemical or exposures investigated.
a Breast development occurs in utero, during puberty, and in early adulthood through the first pregnancy. K.M. Rodgers et al. Environmental Research 160 (2018) 152-182 induction (DeCastro et al., 2006; IARC 2016b; Soto et al., 1995) . Individual differences in PCB metabolism-for example, polymorphisms in CYP1A1 may lead to increased formation of carcinogenic PCB metabolites-may also influence response to exposure . Hydroxy-PCB metabolites appear more estrogenic than parent PCBs (Blair et al., 2000) . More recent tests for genotoxicity that include metabolic activation have found that many PCB congeners produce increased DNA adducts and oxidative metabolites, which may damage DNA (Jeong et al., 2008; Ludewig et al., 2008; Spencer et al., 2009 ).
3.1.2.2. Epidemiologic studies. We reviewed 24 studies of PCBs and breast cancer in 15 countries, including three meta-analyses (Table S3) . While most measured PCBs in serum, a few assessed exposure in adipose tissue, and several combined job history questionnaires or plant records with JEMs. Nine studies did not meet our criteria for discussion. To differentiate different mixtures, investigators took various approaches to define exposure groups, for example grouping by higher and lower chlorination, binding affinity to AhR and ER, or phenobarbital-like CYP induction, primarily based on groupings proposed by Wolff et al. (1997) . Studies also analyzed individual congeners.
Some studies found positive associations with the PCBs identified by Wolff et al. (1997) as CYP1A/2B phenobarbital-type inducers, which may toxify other chemicals or affect hormone levels. The strongest study design, from the CHDS, measured serum PCBs in women who had just given birth between 1959 and 1967, a period of peak PCB use, and followed them to age 50 (Cohn et al., 2012) . The study is of particular interest because exposures during pregnancy reflect a vulnerable window when breast cells are rapidly proliferating and, in a first fullterm pregnancy, differentiating. CYP-inducing congeners as a group were not associated with breast cancer in the CHDS, but analysis by individual congeners showed that women in the highest quartile of PCB 203 exposure had six times higher odds of breast cancer compared to women in the lowest quartile (OR 6.34; 1.85-21.73; p trend < 0.001).
Across other studies of CYP-inducing PCBs, blood levels at the time of diagnosis were positively associated with overall breast cancer (Arrebola et al., 2015; Pastor-Barriuso et al., 2016; Recio-Vega et al., 2011) , some tumor sub-types (Arrebola et al., 2016) and worse survival among cases (Parada et al., 2016a) , though these findings were mostly non-significant. Meta-analyses that included Cohn et al. (2012) produced significant positive meta-ORs for individual CYP-inducing congeners PCB 99 and 183 (Leng et al., 2016) , and for CYP-inducer groupings and individual congeners (PCBs 99, 153, 180, 183 and 203) (Zhang et al., 2015) . On the other hand, Brauner et al. (2014) did not find an association for a group of CYP-inducing congeners in prospectively collected buttock adipose tissue from postmenopausal women in the Danish Diet & Health Study (DDHS), and Holmes et al. (2014) observed non-significant negative associations for individual CYP-inducing congeners in a case-control study of Alaskan Natives. Inconsistent findings may be the result of measuring different congeners and groupings in different tissue types (blood vs adipose), using different methods of control for serum lipids, and/or methodologic problems, particularly regarding the appropriateness of controls in some studies (Arrebola et al., 2015; Holmes et al., 2014; Recio-Vega et al., 2011) (Table S3) .
Other congeners and groupings of interest include potentially estrogenic PCBs and dioxin-like PCBs. Recio-Vega et al. (2011) found significantly elevated odds for estrogenic PCBs among post-menopausal women, and Leng et al.'s (2016) meta-analysis indicated a positive association for potentially estrogenic PCB 187. The Zhang et al. (2015) meta-analysis reported increased risk for the AhR-active PCB grouping, and Parada et al. (2016a) observed non-significantly worse 5-year survival among cases with higher limited dioxin-like anti-estrogenic PCBs in the LIBCSP. In contrast, the AhR-active PCB 167 and estrogenic 187 were protective in CHDS (Cohn et al., 2012) , and a higher ratio of 203 to the sum of 167 and 187 increased risk, while Brauner et al. (2014) found no evidence of association for any congener groupingsincluding potentially estrogenic and dioxin-like -among postmenopausal women in the DDHS. These findings demonstrate that effects may vary by timing of exposure and congener or congener ratios, which is consistent with the diverse biological activity of the congeners. Analyses that examined a sum of individual congeners (Itoh et al., 2009; Roy et al., 2015) or estimates of total PCBs (Gatto et al., 2007) tended to have null or significantly negative ORs, except for Recio-Vega et al. (2011), discussed above, possibly because total PCB measures are not sensitive to the different biological activities of the congeners.
Our previous review summarized studies showing PCB exposure increased breast cancer only among women with a particular CYP1A1 polymorphism , and this remains an interesting area for further study, because CYPs can affect both PCB metabolism and endogenous hormone levels. In one study that considered CYP polymorphisms, there was no evidence for effect modification of the PCBbreast cancer relationship by COMT or CYP1B1 polymorphisms in postmenopausal Danish women (Brauner et al., 2014) . The only other study of PCBs and CYP interaction was not able to consider confounders beyond age and serum cotinine because of the small sample size (Ghisari et al., 2014 ) (see Table S3 ).
In occupational settings, incidence was elevated with increasing cumulative PCB exposure (HR 1.33; 95% CI: 1.14-1.56) among nonwhite women, but decreased among white women, in a cohort of female employees at U.S. capacitor manufacturing plants (Silver et al., 2009 ). However, the non-white women had higher PCB exposure and nearly all were employed at one plant, suggesting a different exposure for these women. As noted in Section 3.1.1, odds of breast cancer were elevated in men with greater exposure to PCBs and dioxins combined (OR 2.1; 95% CI: 1.0-4.5; based on 9 cases with ≥ median exposure) (Villeneuve et al., 2010) .
Since PCBs have a mix of activities and different exposure sources lead to different patterns of congeners, future studies in general populations should consider evaluating congener profiles (e.g. from indoor air or from fish) separately, although this may not be necessary in occupational studies when the exposure profile is consistent within the group. In addition, given that so many studies have relied on the biological-activity congener groups proposed by Wolff et al. (1997) , it might be worthwhile to update the definitions with modern mechanistic tests. A stronger basis for predicting the likely exposure scenarios associated with different congener fingerprints in blood would make it easier to group study participants with most-similar exposures (timing and sources), and this could strengthen analyses.
DDT/DDE and organochlorine pesticides
Exposure to OCPs such as DDT, aldrin, endrin, and dieldrin has decreased since the 1970s and 1980s, when these once widely-used pesticides were banned or phased out in many countries, but they are still found in blood, urine, and environmental samples. The World Health Organization recommends indoor spraying of DDT under certain conditions for malaria control (WHO, 2011) . Lindane and dicofol are still used for lice control (CDC, 2016) and on cotton and fruit crops (U.S. EPA, 1998), respectively.
3.1.3.1. Biological evidence. OCPs display diverse endocrine activity in vitro and in animal models. Kojima et al. (2004) tested 29 OCPs in estrogen receptor alpha (ERα), estrogen receptor beta (ERβ), and androgen receptor (AR) transactivation assays that test for receptor agonism/antagonism; 11 OCPs, including o,p′-DDT, p,p′-DDT, p,p′-DDE, p,p′-DDD, cis-and trans-chlordane, dicofol, and heptachlor epoxide showed positive activity for all three tests of ERα and ERβ agonism and AR inhibition. Anti-androgenic activity has been reported for DDE, a metabolite of DDT that bioaccumulates in meat and dairy products (Kelce et al., 1995) . Androgenic action may reduce estrogendriven cell proliferation, but anti-androgenic action may have the reverse effect, as has been demonstrated in pre-pubertal mice with localized DDE exposure (Johnson et al., 2012) . DDT and other OCPs also induce CYP enzymes (Li and Kupfer, 1998) , which mediate metabolism of estrogen and other toxicants. Several studies show that low levels of OCPs can act additively, for example inducing cell proliferation in MCF-7 cells (Scholze et al., 2014; Soto et al., 1994) .
Experimental studies in animals have shown specific effects on the mammary gland or on cancer. Rats exposed during puberty to o,p′-DDT had increased cell proliferation in terminal structures, which differentiate into alveolar and lobular structures during puberty and pregnancy (Brown and Lamartiniere, 1995) . Rats exposed in utero to dieldrin had under-developed alveolar structures in the mammary gland (Tarraf et al., 2003) . Hexachlorobenzene (HCB) increases serum estrogen levels in adult rats and stimulates human epidermal growth factor 1 (HER1) pathway in mammary tumors (Pena et al., 2012) .
A 2015 IARC summary statement classified lindane as carcinogenic based on non-Hodgkin Lymphoma in agricultural workers and DDT as probably carcinogenic to humans based on non-Hodgkin Lymphoma and testicular cancer in case-control studies. The statement notes mixed results for breast cancer in humans with early life exposure to DDT (IARC, 2015) , but it was published before the Cohn et al. (2015) study of in utero exposure, discussed below. Dieldrin and aldrin (which is metabolized to dieldrin) were classified as probably carcinogenic to humans based on breast cancer and on liver tumors in animal studies (IARC 2016c) . IARC lists chlordecone, HCB, mirex, and toxaphene as reasonably expected to be carcinogenic to humans, and has thus far noted insufficient data for chlordane, heptachlor, hexachlorocyclohexane (HCH) and methoxychlor (IARC, 1979) . The 2016 NTP Report on Carcinogens maintained IARC's (1979) classifications (NTP, 2016b).
Epidemiological studies.
We identified 24 studies of OCPs; fifteen met our criteria for discussion (Table S4) , with all but two measuring OCPs in blood or adipose tissue. DDT remains the moststudied OCP in relation to breast cancer. DDE, a breakdown product and persistent metabolite of DDT, is frequently measured as an indicator for lifetime DDT exposure. New findings continue to show little evidence of association between late-life DDE residues and breast cancer (Arrebola et al., 2015; Boada et al., 2012; Gatto et al., 2007; Holmes et al., 2014; Ingber et al., 2013; Itoh et al., 2009; Xu et al., 2010) . However, DDE levels reflect both metabolized DDT and direct exposure to DDE in diet and likely do not correctly rank individuals with regard to DDT exposure (Snedeker, 2001) . Case-control studies that measured o,p-DDT and p,p-DDT at diagnosis were also generally null (Boada et al., 2012; Holmes et al., 2014; Itoh et al., 2009) .
Several studies since 2006 took new approaches that help address exposure assessment challenges. For example, Parada et al. (2016b) measured DDT at diagnosis and analyzed 5-year survival among breast cancer cases in the LIBCSP. Women in the second and third tertiles of p,p′-DDT serum levels had significantly higher odds of dying of breast cancer. The LIBCSP and Sister Study both assessed acute DDT exposure early in life by asking women whether they had seen or chased after fogger trucks. Findings suggested increased risk for premenopausal breast cancers among Sister Study participants who reported this exposure (Niehoff et al., 2016) and elevated odds of ER+/PR+ tumors in the LIBCSP (White et al., 2013) . Recall bias is a concern, but these assessments that capture a biologically relevant exposure period are more persuasive than blood measures from adult women long after DDT was banned.
The most compelling new analyses came from the Child Health and Development Studies (CHDS), the only study with blood samples obtained while DDT was in use. CHDS took advantage of a unique quasiexperiment within the cohort, which comprises women born both before and after DDT came into widespread use in 1945. Among women who could have been exposed during early life because they were younger than 14 in 1945, those in the highest tertile of serum p,p′-DDT had five times higher odds of developing breast cancer before age 50 than women in the lowest tertile (Cohn et al., 2007) . Conversely, o,p′-DDT was inversely associated with breast cancer. The authors theorize that p,p′-DDT is a better measure of childhood exposure, because it is more persistent, or the differing effects could be due to different metabolic intermediates. A subsequent analysis captured in utero exposure by following daughters born to the CHDS mothers. With follow-up through age 52, odds of breast cancer were significantly elevated in daughters whose mothers had higher levels of o,p′-DDT, (OR 3.7; 95% CI 1.5-9.0) at the time of their births. Higher levels of o,p′-DDT were also associated with higher odds of human epidermal growth factor receptor 2 (HER2) positive breast cancer (OR 4.6; 95% CI 1.1-19.7) (Cohn et al., 2015) . The authors suggest that o,p'-DDT may be a better measure of current exposure (prenatal for the daughters), since it is rapidly metabolized, while p,p′-DDT may be a better measure for the analysis in the mothers, where blood levels during pregnancy were used to estimate earlier adolescent exposures (Cohn et al., 2015) .
The only other analysis of DDT measured in prospectively collected samples -the Japan Public Health Center-based Prospective (JPHC) Study -obtained blood samples 10-15 years after DDT was banned from women aged 40-69 (Iwasaki et al., 2008) . After 7-12 years of follow-up, the study found no overall associations between p,p′-DDT or DDE and breast cancer, although ORs were non-significantly increased among premenopausal women in the highest quartile of p,p′-DDT (OR 2.45; 95% CI 0.70-8.63) and p,p′-DDE (OR 2.30; 95% CI 0.73-7.23). In addition to the timing of exposure measurement, an important difference between CHDS and JPHC is that the effect estimates for particular DDT components in CHDS were mutually adjusted for other DDT-related compounds (See Table S4 ), an approach meant to account for concurrent exposure to the technical mixture and its metabolites. JPHC did not use this method (Iwasaki et al., 2008) . Statistical methods for analyzing exposure to mixtures of chemicals are currently an important area of study (Taylor et al., 2016) .
Several studies reported findings for OCPs other than DDT. A metaanalysis of studies from 1966 to 2006 suggested that geometric mean levels of heptachlor were significantly higher in cases than controls and that odds of breast cancer were higher for women with higher blood levels of aldrin (Khanjani et al., 2007) . Both findings were based on two studies. There have been a few positive findings in the past 10 years for β-HCH and breast cancer in case-control (Arrebola et al., 2015; Holmes et al., 2014) and cross-sectional (Xu et al., 2010) studies; for HCB and tumor characteristics (positive association with ER+ and with HR+, negative association with E-cahderin) (Arrebola et al., 2016) . However, Iwasaki et al. (2008) found no evidence for effects of any of these chemicals in the prospective JPHC Study. Differences in findings could reflect underlying differences in absolute levels and/or the distribution of levels in the populations studied, but inconsistent reporting of crude versus lipid-standardized values prevents evaluation of this possibility. In the LIBCSP, five-year survival among cases was worse for the upper versus lower tertile of chlordane in blood (Parada et al., 2016b) . This association was only significant when controlling for lipids as an independent covariate, rather than lipid-standardizing values, emphasizing that the choice of method for lipid control can be critical.
Xenoestrogen burden
A new approach to exposure assessment for diverse mixtures of EDCs is to use functional assays of a specific biological activity to provide an integrated measure. Serum is usually divided into more-and less-polar fractions. Polar fractions include endogenous estrogens as well as some EDCs, such as nonylphenol. Less polar fractions contain persistent EDCs like PCBs, DDT, and other OCPs.
Two studies used a functional assay to measure estrogenic activity in serum in relation to breast cancer (Bonefeld-Jorgensen et al., 2011; Pastor-Barriuso et al., 2016) . In a case-control study in Spain, PastorBarriuso et al. (2016) used the E-screen assay (Soto et al., 1995) to measure total xenoestrogen burden (TEXB). The upper versus lower tertile of lipophilic xenoestrogen burden (TEXB-α) was associated with 3 times the odds of breast cancer (OR, 3.45; 95% CI: 1.50-7.97). This association was attenuated in a model that mutually adjusted for the fraction containing endogenous hormones and polar xenoestrogens (TEXB-β) (OR, 1.80; 95% CI: 0.63-5.09), but as the authors discuss, adjusting for the TEXB-β fraction could introduce rather than reduce bias by creating a negative association between the TEXB-α fraction and endogenous hormones. Bonefeld-Jorgensen et al. (2011) reported no difference in xenoestrogen activity (based on 7 cases) but significantly elevated androgenic activity in the lipophilic serum fraction in a small number of cases compared to controls among Inuit women, a population highly exposed to persistent pollutants.
Non-organochlorine or unspecified pesticides
Exposure assessment for non-persistent pesticides poses additional challenges beyond those already discussed, because even if biological samples are obtained during a relevant etiologic period, exposure to these chemicals is generally episodic and no lasting markers of exposure have been identified. The studies reviewed here assessed exposure using (1) self-report of occupational or personal pesticide use or (2) modeling based on geographic location in combination with sampling of nearby wells or records of agricultural land use or pesticide application.
Biological evidence
Organophosphate (OP) pesticides such as parathion, malathion, and chlorpyrifos are acetylcholinesterase (AcE) inhibitors. Concerns have focused on neurotoxicity (U.S. EPA, 2014, 2016b) but experimental evidence indicates OPs may also affect mammary gland development and endocrine pathways. For example, Cabello et al. (2001) reported increased TEB formation and mammary tumors in rats exposed during late puberty to malathion or parathion at levels high enough to inhibit AcE. Eserine, another AcE inhibitor, produced similar outcomes, and effects were blocked by atropine, which competes with AcE inhibitors, suggesting these OPs may act on the mammary gland through an AcE mechanism (Cabello et al., 2001 ). In another study, malathion, estradiol, and the two combined altered mammary gland structure and induced mammary tumors in rats (Calaf and Echiburu-Chau, 2012) . On the other hand, chlorpyrifos altered mammary gland development and circulating hormone levels at doses below US Environmental Protection Agency's (EPA) benchmark dose for AcE inhibition, indicating AcE may not be the most sensitive endpoint (U.S. EPA, 2014; Ventura et al., 2016) . Effects on mammary gland development are not captured in recent EPA evaluations for these pesticides (U.S. EPA, 2014, U.S. EPA, 2016b).
The common herbicide atrazine also affects mammary gland development in rodents. Rats exposed in utero experienced delayed mammary gland development that persisted into adulthood (Rayner et al., 2005) . Atrazine exposure in adult rats increased mammary tumors; however, it also produced persistent estrus, leading some reviews to conclude that this mechanism is not relevant to humans (Cooper et al., 2000; FIFRA, 2000) . EPA's atrazine registration used inhibition of gonadotropin-releasing hormone from rodent hypothalamus as the basis for the protective benchmark dose (U.S. EPA 2006c). Enoch et al. (2007) reported rat mammary gland changes following exposure to atrazine metabolites at levels found in drinking water below the EPA benchmark dose.
Epidemiological studies
We identified 15 studies of organophosphate pesticides, atrazine, fungicides, or unspecified pesticides (Table S5 ). Most did not collect information on timing, duration, or intensity (e.g. frequency) of exposure. Many relied on retrospective self-reports that are vulnerable to recall bias, but two prospective studies, the Agricultural Health Study (AHS) and Sister Study, avoid this problem. Exposure misclassification can still be a concern because of difficulty accurately reporting product use. For home pesticides, specific chemicals were not identified, although we know that chlorpyrifos and diazinon were often used in homes from the 1950s-60s until the early 2000s (U.S. EPA, 2006a,b) .
Among studies of particular pesticides, follow-up of spouses in the AHS provided the first evidence for an association between personal application of organophosphate pesticides and breast cancer (Lerro et al., 2015) . Breast cancer risk was higher among wives who reported use of any of 10 OP pesticides before enrollment (Lerro et al., 2015) . Analyses of individual pesticides suggested that chlorpyrifos (RR, 1.41; 95% CI: 1.00-1.99) and terbufos (RR 1.52; 95% CI: 0.97-2.36) might be driving the overall association. A study in rural Wisconsin found no association between modeled residential atrazine levels in drinking water and breast cancer, but only 9 women had estimated exposures above the U.S. EPA maximum contaminant level (McElroy et al., 2007) . The other atrazine study did not meet our criteria for discussion.
Four studies examined living on or near agricultural land. The Sister Study found higher breast cancer risk among women who lived on a cotton or tobacco farm (but not on or near a farm in general or any other type of farm) for at least 12 months before age 18 (Niehoff et al., 2016) . El-Zaemey et al. (2013) observed increased breast cancer for women who had lived near a farm and noticed pesticide drift, with a stronger association among women who first noticed drift before age 20. The authors used sensitivity analyses to evaluate possible effects of recall bias; assuming 10% over-reporting by cases and 20% under-reporting by controls; risk estimates were still positive but no longer significant. A case-control study of living in areas with fungicide use on Prince Edward Island, Canada, found no association, but the authors note that all residents, including the "reference group," may be exposed at high levels (Ashley- Martin et al., 2012) . Brody et al. (2006) found no association between breast cancer and drinking water from areas impacted by pesticide application.
Several studies examined self-reported home or occupational use of unspecified pesticides. The Cape Cod Breast Cancer and Environment Study found elevated odds of breast cancer among women who used insect repellents often or very often compared to never (OR, 1.5; 95% CI: 1.0-2.3) (Zota et al., 2010) , while the LIBCSP found no association for insect repellents but higher risk in all quintiles of lifetime applications of indoor and lawn/garden pesticides (no evidence of dose response) (Teitelbaum et al., 2007) . Differences between Cape Cod and the LIBCSP could reflect differences in regional pesticide practices, particular questions asked, and/or greater statistical power in the larger LIBCSP. By contrast, studies in New York (Farooq et al., 2010) and Australia (El-Zaemey et al., 2014) found little evidence of association between outdoor or indoor home-pesticide use and breast cancer. The Cape Cod Study also tried to evaluate recall bias by stratifying analyses by whether participants' believed that chemicals contribute to breast cancer (Zota et al., 2010) . The theory is that if a positive association is driven by recall bias, it will only occur among women who believe that chemicals or pesticides cause breast cancer. However, comparing results with a parallel analysis of family history (a risk factor known to be reported with little bias) suggested this strategy can be misleading in attributing effects to recall bias (Zota et al., 2010) . Studies of self-reported occupational exposure found no association but were limited by relatively small numbers (< 65) of exposed women (Ekenga et al., 2015a; El-Zaemey et al., 2014) ; one study in men also reported no association for high vs never exposure, based on 10 exposed cases (Villeneuve et al., 2010) .
Additional follow-up from prospective studies like the AHS and Sister Study may shed light on effects of current use pesticides. Synthetic pyrethroids, for example, have a range of endocrine effects, including estrogenic activity in breast cancer cell lines (Go et al., 1999; Mnif et al., 2011) . The use of these chemicals in some insect repellents may underlie the elevated OR in the Cape Cod Study (Zota et al., 2010) . Only Lerro et al. (2015) examined tumor subtypes and reported that the association for chlorpyrifos might be specific to ER-/PR-tumors, based on 11 cases.
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Polycyclic aromatic hydrocarbons, air pollution, vehicular exhaust
Air pollution comprises pollutants from many sources, including power generation, transportation, and industry. Components include particulate matter (PM); metals; air toxics, including volatile organic compounds (VOCs); polycyclic aromatic hydrocarbons (PAHs, formed by combustion of organic materials and commonly found in cooked foods); and nitro-PAHs, which are generated largely from diesel-powered vehicles.
Biological evidence
IARC designates outdoor air pollution as carcinogenic to humans based on mechanistic, animal, and epidemiological evidence (IARC 2016a). Many individual air pollutants are genotoxic, and some are estrogenic or anti-estrogenic. In toxicological and epidemiologic studies, PM has been found to induce oxidative stress, which can form free radicals that damage DNA, and inflammation, which can lead to changes -including oxidative stress -that contribute to cancer (reviewed by Valavanidis et al. (2008) ).
PAHs are the most-studied component of air pollution in relation to breast cancer and include hundreds of compounds and their metabolites with different biologic activities. The NTP and IARC identify 15 PAHs and several nitro-PAHs as reasonably anticipated to be human carcinogens (IARC, 2013; NTP, 2016b) . Rudel et al. (2014) identified 13 PAHs and nitro-PAHs that specifically caused mammary gland tumors in animal models.
Like PCBs, PAHs have anti-estrogenic and estrogenic activity. Many bind with the AhR, activating CYP-mediated metabolism and producing DNA-reactive metabolites and oxygen radicals that can form DNA adducts and, in turn, genetic mutations (IARC 2010a). Because the AhR influences expression of CYP1A1, CYP1A2, and CYP1B1 enzymes, risk from individual PAHs may be related to their AhR binding affinities (Nebert et al., 2004) . Anti-estrogenic effects are hypothesized to arise from CYP1A1 induction (Santodonato, 1997) and from AhR-ER crosstalk (Arcaro et al., 1999; Matthews and Gustafsson, 2006) . Conversely, hydroxyl-PAH metabolites have been shown to be estrogenic in vitro and in vivo (Kummer et al., 2008; Nishihara et al., 2000; Van de Wiele et al., 2005) . PAHs also activate CYP3A4 via PXR receptor (Luckert et al., 2013) , and in this way can affect estrogen metabolism. Genetic variations in the CYP and GST gene families may affect PAH metabolism, and other genes, such as those involved in DNA repair, tumor promotion, and apoptosis, affect the cascade of events on pathways to cancer, so these may modify response to PAHs and are good targets for subgroup analyses in epidemiological studies.
Some VOCs from vehicle exhaust, including 1,3-butadiene, ethylene oxide (EtO), and benzene (also in gasoline), are human carcinogens with strong evidence of genotoxicity and increased mammary tumors in animal models (IARC 2012a; NTP, 2016b; Rudel et al., 2007) . We review the mechanistic action of benzene and EtO in sections on organic solvents (Section 3.6) and occupational exposures (Section 3.7), respectively.
Epidemiologic studies
Breast cancer studies of PAHs and air pollution increased notably in the past 10 years, with nearly 50 new reports, although several did not meet our criteria for discussion (See Table S7 ). Measuring DNA adducts in blood and modeling residential air pollution were common exposure assessment methods; a few studies used questionnaires for occupational exposure. Self-reported residential and occupational history are considered reliable measures (Reider and Hubble, 2000; Teschke et al., 2002) , though reports of specific agents at work could be susceptible to recall bias or non-differential misclassification.
3.3.2.1. Biomarker studies. Biomarkers of PAHs include bulky DNA adducts and PAH-DNA adducts in blood and PAH metabolites in urine. These are thought to capture exposure from air pollution, tobacco, and diet. PAH-DNA adducts are considered an early effect marker for cancer. Bulky adducts are non-specific, capturing adducts of aromatic amines, hormones, and other hydrophobic compounds in addition to PAHs. Both methods often use white blood cells, which represent exposures over weeks to months, an advantage over urinary metabolites, which reflect exposures over days (Godschalk et al., 2003; Miller-Schulze et al., 2013) . Measurement in normal tissue is rarely available, but Rundle et al. (2000) found an association between PAH-DNA adducts in breast tissue and breast cancer, using reduction mammoplasty samples as controls.
One difficulty in interpreting adducts as exposure measures is that they have not been consistently related to self-reported PAH sources. For example, smokers do not consistently have higher bulky-or PAH-DNA adduct levels than non-smokers (Gammon et al., 2002; Saieva et al., 2011) . One possibility is that the presence of adducts is governed more strongly by genetic variation in response to PAHs rather than exposure, as reviewed by Gammon and Santella (2008) . In this case, the biological measures might help distinguish "susceptibility X exposure" groups.
The LIBCSP analyzed gene-adduct interactions using PAH-specific DNA adducts and, as reported in our 2007 review, found associations between PAH-DNA adducts and premenopausal breast cancer ; a non-significant additive interaction between PAH-DNA adducts and the XRCC1 399Gln allele, important for DNA repair, among never-smokers (Shen et al., 2005) ; and a significant joint effect of adduct levels and the Gln/Gln genotype of XPD, a gene involved in nucleotide excision repair (NER) (Terry et al., 2004) . The LIBCSP also previously reported positive associations between lifetime smoked/ grilled food intake and postmenopausal breast cancer; smoking and ER +/PR+ tumors; long-term exposure to environmental tobacco smoke and breast cancer; and estimated traffic-related PAH exposure during early life, menarche, and before first childbirth and breast cancer (Gammon and Santella, 2008) .
New LIBCSP results added to the findings for DNA repair genes (Table S6) . Crew et al. (2007b) evaluated additional NER pathway genes and reported a significant joint OR for PAH-DNA adduct levels above the median and a different XPD polymorphism (Asn/Asn genotype) as well as a non-significant multiplicative interaction between detectable adducts and variant alleles for ERCC1, which may affect mRNA stability. The association between detectable adducts and breast cancer was higher in LIBCSP women with a polymorphism of IGHMBP2, but the interaction was not significant (Shen et al., 2006) .
The LIBCSP also considered genes associated with tumor suppression and apoptosis. Interestingly, odds of ER+/PR+ breast cancer were significantly elevated among cases with detectable PAH-DNA adducts and methylated versus unmethylated RAR-β promoter (measured in tumor tissue) on the multiplicative scale (p interaction , 0.03), and nearly significantly elevated among cases with methylated versus unmethylated APC promotor (p interaction , 0.09) (White et al., 2015) . RAR-β and APC are tumor suppressor genes, with APC implicated in DNA repair, so promotor methylation could inactivate these genes and prevent effective anti-tumor activities (White et al., 2015) . There was suggestive evidence that the apoptosis-related FAS1377 gene might modify the association between PAH-DNA adducts and breast cancer (Crew et al., 2007a) , and limited evidence for effect modification by polymorphisms or mutations of TP53, a tumor suppressor gene (Gaudet et al., 2008; Mordukhovich et al., 2010) . Mordukhovich et al.'s (2010) analysis indicated that PAH adducts might be associated with particular subgroups of p53 mutations (e.g., frameshift mutations) that occurred in a small number of tumors, but the estimates were not significant.
Only one new analysis in the LIBSCP considered genes involved in PAH metabolism. Results suggested that women with detectable PAH-DNA adducts and any three polymorphisms in the GST gene, a gene involved with PAH metabolism, had significantly elevated odds of breast cancer (McCarty et al., 2009 ), though the statistical test for interaction was not significant (p, 0.43). A previous LIBCSP report found that GSTA1 variant alleles and smoking were associated with increased breast cancer risk (Ahn et al., 2006) , but other analyses were inconclusive (Terry and Goodman, 2006) . Additional investigation into variations in CYP enzymes could be helpful. For example, studies have shown that among coke oven workers, variations in DNA adduct levels are associated with CYP mutations Zhang et al., 2000) .
Of note, several gene variants analyzed in the LIBCSP did not appear to modify the association between PAH-DNA adducts and breast cancer. These included polymorphisms of NER pathway genes XPA, XPF, XPG (Crew et al., 2007b) , and XPC (Shen et al., 2008) and methylation status of ESR1, PGR, BRCA1, CCND2, CDH1, DAPK1, GSTP1, H1N1, CDKN2A, RASSF1A, and TWIST1 (White et al., 2015) .
Findings from prospective studies used different exposure measures from the studies reviewed thus far. In the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort, Saieva et al. (2011) examined bulky DNA adducts in Italian women and reported a weak, non-significant association, while Lee et al. (2010) found no association for urinary biomarkers of PAH metabolites and oxidative stress in the Shanghai Women's Health Study. Potential considerations include the following: (1) urinary metabolites capture exposure during a very brief window (days), as compared to DNA adducts (months) and self-report/location-based exposure estimates (years), (2) PAH metabolites do not capture individual differences in DNA repair capacity and (3) bulky adducts are not specific to PAHs, though the method for measuring them is more sensitive than the ELISA method for PAH adducts Saieva et al., 2011) .
Additional evaluation of a role for PAHs in tumor progression, as suggested by an earlier case-control study (Tang et al., 2002) , would be of interest, as would studies that analyze specific PAH mixtures, such as occupational exposures. The one analysis that examined survival in the LIBCSP did not find strong evidence of an association, but it lacked information about stage at diagnosis, which could be critical, and did not consider gene interactions (Sagiv et al., 2009 ). New, more-specific PAH-DNA adduct measures could help differentiate exposure sources.
Job history and geographic location studies.
A few case-control studies assessed PAHs and vehicle exhaust using job history, which has the advantage of integrating exposures over time and clarifying the exposure source. In Canada, Labreche et al. (2010) estimated lifetime occupational PAH exposure among postmenopausal women using job questionnaires and found higher odds of breast cancer for each 10-year increase in duration of exposure. Odds ratios were highest for exposure before age 36 and particularly from petroleum sources (OR per 10-year increase, 2.38; 95% CI: 1.00-5.67) compared to PAHs from any source (OR per 10-year increase, 1.75; 95% CI: 0.99-3.10). The Sister Study similarly found increased breast cancer risk with higher levels of exposure to gasoline or petroleum products (Ekenga et al., 2015a) , and Rai et al. (2016) found non-significantly elevated odds of premenopausal breast cancer with occupational exposure to diesel and gasoline exhaust.
The most common method for air pollution exposure assessment, however, was geographic location, and several interesting findings came from studies that captured relevant biological features. Among studies that considered tumor subtypes, significantly higher risk of ER+/PR+ tumors was reported per 5.8 ppb NO 2 estimated at baseline address in the Sister Study (HR, 1.10; 95% CI: 1.02-1.19, p interaction , 0.04) (Reding et al., 2015) . The California Teachers Study (CTS) found significant positive associations between ER+/PR+ tumors and upper versus lower quintile of some ambient mammary gland carcinogens estimated at the census-tract level at the midpoint of the 1995-2011 study period (NATA 2002 data) , as well as significantly elevated risk of ER-/PR-tumors for the upper vs. lower quintiles of ambient benzene , cadmium, and arsenic (R Liu et al. 2015 ). In the LIBCSP, Mordukhovich et al. (2016a) estimated residential traffic-related PAHs and reported a significant elevation in ER-/PR-breast cancer compared to other subtypes for recent traffic-PAH ≥ 95th versus < 50th percentile. Follow-up examining nine NER and base excision repair genetic variants found significantly elevated joint odds of breast cancer among women with the Gln/Gln genotype of XPD and the highest tertile of estimated traffic-PAH (OR, 2.09; 95% CI: 1.13-3.90, p interaction , 0.04) (Mordukhovich et al., 2016b) , which is consistent with the previously reported interaction between XPD and PAH-DNA adducts in the LIBCSP (Terry et al., 2004) . On the other hand, Hart et al. (2016) did not find an association between estimated residential PM and tumor subtypes over 18 years of follow-up in the Nurses Health Study II, which could reflect a true lack of association, or that the other studies used different measures of air pollution or captured tumor promoting effects close to diagnosis. Only a few studies considered early life exposure or menopausal status. A case-control study using the LIBCSP model to estimate traffic-related PAHs in Western New York found that women with the highest compared to lowest exposures at menarche had elevated risk of premenopausal breast cancer (OR 2.07; 95% CI: 0.91-4.72) (Nie et al., 2007) . In this study, exposure at menarche was not known for postmenopausal women, but exposure at first birth was associated with significantly increased risk (OR 2.58, 95% CI: 1.15-5.83). Both of these associations were stronger among non-smokers. In a Canadian study, odds of breast cancer were non-significantly elevated among premenopausal women living within 3.2 km of petroleum refineries (based on 8 cases) and steel mills (Pan et al., 2011) .
For overall breast cancer, results from studies of geographic location and air pollution were mixed. Prospective studies of modeled residential PM 2.5 , PM 10 , NO 2 or NO X (considered markers of traffic pollution) were mostly null (Hart et al., 2016; Raaschou-Nielsen et al., 2011; Reding et al., 2015) , while case-control studies showed nearly significant positive findings for NO 2 and breast cancer (Crouse et al., 2010; Hystad et al., 2015; Shekarrizfard et al., 2015) . PM and NO x were not considered in case-control studies. The difference in findings between studies of NO 2 may be because the analysis from the prospective Sister Study did not stratify by menopausal status (Reding et al., 2015) , while the case-control studies were either limited to postmenopausal women (exposure estimated at diagnosis) (Crouse et al., 2010) or presented stratified results suggesting a somewhat stronger association among premenopausal than postmenopausal women, for exposure based on 18 years of residential history (Hystad et al., 2015) . Findings from two prospective analyses of residential proximity to major roadway were also mixed; the Nurses Health Study reported non-significant positive associations with closer proximity (Hart et al., 2016) , while the Danish Diet, Cancer and Health Study found no association (Raaschou-Nielsen et al., 2011) . EPA 2002 census-tract estimates of several ambient endocrine disruptors (including diesel) (R Liu et al. 2015) and mammary carcinogens were not associated with overall breast cancer in the prospective CTS.
Interestingly, when White et al. (2016) considered various PAH sources (active smoking, residential environmental tobacco smoke (ETS), diet, traffic-related and indoor stove/fireplace use) in the LIBCSP together in one mixed effects model, ORs for individual sources all remained elevated, with p < 0.05 for synthetic log burning and residential ETS from spouse. The highest OR was for exposure to several PAH sources (smoking, residential ETS from spouse, grilled/smoked meat intake, and stove/fireplace use) compared to low or no exposure to all sources (OR, 1.45; 95% CrI: 1.02-2.04), and results were similar but not significant when high exposure to traffic-related PAHs was included in the model, based on 9 cases and 9 controls exposed to all PAH exposure sources. White et al. (2014) also found a significant positive association for synthetic log burning, and that GST variants may increase breast cancer risk with greater frequency of log burning.
Consumer product chemicals
The focus on consumer product chemicals and breast cancer increased since 2006, pursuing hypotheses from animal studies. We K.M. Rodgers et al. Environmental Research 160 (2018) 152-182 reviewed studies of bisphenol A (BPA), phthalates, nonylphenols, hair dyes and straighteners, per-and polyfluorinated alkyl substances (PFASs), and flame retardants (Table S8 ). Exposure to consumer product chemicals is commonly assessed in blood or urine. Important considerations for exposure assessment include the rapid metabolism of some of these chemicals, including BPA and phthalates. Consequently, blood levels may not accurately reflect exposures, and intra-individual variability is high from spot urine samples, so single urine measures may not represent long term exposures (Calafat et al., 2013) . In addition, sample contamination is a concern because some of these chemicals are used in sample collection containers and some are in laboratory equipment. While self-reported product use is employed in major cohorts (Taylor et al., 2017; Zheng et al., 2005) , only hair dye was assessed by self-report among the studies we reviewed here. Selfreports are subject to recall bias in case-control studies and non-differential misclassification in all studies.
3.4.1. BPA Bisphenol A, synthesized in 1891 as a synthetic estrogen, has been used since the 1950s to make highly durable plastics such as polycarbonate. Food packaging appears to be the major source of exposure for the general population (Rudel et al., 2011b) .
3.4.1.1. Biological evidence. BPA's endocrine disrupting abilities have been demonstrated in numerous experimental studies, including cell proliferation in estrogen-sensitive breast cancer cell lines (AlonsoMagdalena et al., 2012; Andersen et al., 1999; Okada et al., 2008; Vandenberg et al., 2009) . US EPA's high throughput chemical testing program, ToxCast™, ranked BPA among the most endocrine active of 309 chemicals based on its activity in estrogen, androgen, and other nuclear receptors (Reif et al., 2010) . In utero and perinatal exposure alters mammary gland development and induces pre-neoplastic mammary gland lesions in rodent studies (Acevedo et al., 2013; Mandrup et al., 2016; Paulose et al., 2015; Tharp et al., 2012) ; pubertal exposure in rats also modifies mammary gland development (Colerangle and Roy, 1997) . In some studies, effects at lowest doses are not observed at higher doses, suggesting possible non-monotonicity in dose response. The free form of BPA (unconjugated) is the active form, and ingested BPA is rapidly metabolized to conjugated metabolites (Doerge et al., 2010 (Doerge et al., , 2011 Taylor et al., 2008 Taylor et al., , 2011 , which are readily detected in urine (Teeguarden et al., 2013) . There is controversy about whether levels of free (active) BPA in human blood are above the level required to produce biological activity (Teeguarden et al., 2013; Vandenberg and Prins, 2016) . A diverse set of approaches to estimating circulating free BPA levels in blood in humans indicate concentrations are in the sub-picomolar range, and most experimental animal studies have used higher doses (Teeguarden et al., 2013 (Teeguarden et al., , 2016 . Higher levels of free BPA in blood may be expected in special exposure scenarios, such as medical settings where IVs deliver fluids containing BPA or workplaces where fumes are inhaled from melting or curing polycarbonate.
3.4.1.2. Epidemiological studies. The one study of BPA that met our criteria for discussion found no evidence supporting an association between conjugated-BPA metabolites and breast cancer (Trabert et al., 2014) . However, the study did not measure exposure in early life, the time when effects are seen in rodent studies, and it used one-time measures, which likely do not reflect individuals' typical exposure (Braun et al., 2012) .
Phthalates
Phthalates are a group of chemicals used as plasticizers in diverse products, including building materials, medical equipment, and food contact materials; they are also used as solvents in many consumer products, including fragrances. Food packaging, vinyl flooring, and plasticizers are major exposure sources of higher molecular weight phthalates, like bis(2-ethylhexyl) phthalate (DEHP), while fragrances and cosmetics are important sources for lower molecular weight phthalates, like diethyl phthalate (DEP) (Harley et al., 2016; Rodgers et al., 2014) .
3.4.2.1. Biological evidence. Many studies have reported endocrine disruption and toxic effects on the developing male reproductive system with exposure to high molecular weight phthalates (Fabjan et al., 2006) . DEP, a low molecular weight phthalate, does not show similar EDC activity (Gray et al., 2000) . A few studies have reported endocrine disruption in females, including changes in progesterone levels in pregnant rats exposed to di-n-butyl phthalate (DnBP) and estradiol levels in primates following in utero exposure to DEHP (Gray et al., 2006; Tomonari et al., 2006) . Altered development of mammary tissue was observed in mice exposed to MEHP in utero (Moyer and Hixon, 2012) and in rats exposed to DnBP in utero through lactation (Lee et al., 2004) . Additionally, a study that exposed adult rats to high levels of DEHP observed decreased estradiol levels and anovulation (Lovekamp-Swan and Davis, 2003) .
Epidemiological studies.
Two hospital-based case-control studies in Alaska and Mexico assessed phthalates and breast cancer using one-time measurements of monoester metabolites in urine. Monoester or oxidative metabolites in urine are the preferred biomarkers because of contamination concerns when measuring parent compounds (Calafat et al., 2013) . In Alaska, Holmes et al. (2014) reported an elevated OR for the DEHP metabolite MEHP (OR 2.43, 95% CI: 1.12-5.24) but not for MEP, which did show an association with breast cancer in the Mexico study (Lopez-Carrillo et al., 2010) . The MEP levels in the Mexico Study (Lopez-Carrillo et al., 2010) were much higher than in Alaska (Holmes et al., 2014) . Although MEP, a metabolite of DEP, is not an EDC, it may be a marker for fragrance or other endocrine-active exposures that could explain the association with breast cancer. Additional analysis of the study in Mexico suggested an association between urinary DEHP metabolites and breast cancer in a subgroup with a polymorphism in the PPARγ gene (Martinez-Nava et al., 2013) . However both the Mexico and Alaska studies were critically limited by the use of one-time urine measurements. As with BPA, phthalates are rapidly metabolized and excreted, so there can be substantial intra-individual variability (Braun et al., 2012) . Intraclass correlation coefficients (ICCs) for repeated samples vary with the specific phthalate and indicate that multiple spot urine samples over multiple days are required to produce a stable exposure estimate (Hauser et al., 2004; Preau et al., 2010) .
Other case-control studies estimated phthalate exposure using selfreport. A large study of European men found non-significantly elevated odds of breast cancer associated with phthalate exposure above the median (with 3 exposed cases), assessed from lifetime occupational history (Villeneuve et al., 2010) . Breast cancer was also significantly associated with frequency of lifetime use of household cleaners and air fresheners in the Cape Cod Study (Zota et al., 2010) . Dodson et al. (2012a) showed these products can contain DEP and DEHP, among other chemicals.
Nonylphenols
Nonylphenols belong to the family of alkylphenols, which are widely used as surfactants in detergents, "inert" ingredients in pesticides, and as additives to some plastics (Dodson et al., 2012a) . Cleaners, detergents, food packaging, cosmetics, and pesticides are major sources of exposure for nonylphenols (U.S. EPA, 2010). They have been phased out of household detergents, and additional restrictions were being considered by EPA (U.S. EPA, 2010). Rodgers et al. Environmental Research 160 (2018) 152-182 breast cancer cells . Rats exposed during puberty showed altered mammary gland development (Moon et al., 2007; Odum et al., 1999) .
3.4.3.2. Epidemiological studies. Villeneuve et al. (2010) found significantly elevated odds of male breast cancer with occupational alkylphenol exposure above the median (OR, 3.3; 95% CI: 1.1-9.9) based on self-reported job history and industrial hygiene assessment.
Hair dyes and straighteners
In the U.S., nearly 75% of women report ever using hair dye (Rollison et al., 2006) , and hair straighteners or relaxers have grown in popularity, with higher use among women of African descent (Gavazzoni Dias, 2015) .
3.4.4.1. Biological evidence. Aromatic amines in some hair dyes raise concern due to their mutagenicity in animal models . Dermal application of common hair dyes resulted in increased mammary tumors in rats but not mice (IARC 2010c). The commonly used hair dye, p-Phenylenediamine (PPD), has been found to be contaminated by 4-aminobiphenyl (4-ABP) (Turesky et al., 2003) , an aromatic amine and known carcinogen, based on bladder cancer (IARC 2010c). Rats subcutaneously treated with 4-ABP also developed mammary tumors (IARC 2010c). 4-ABP DNA adducts from breast milk were associated with Arkansas women's use of hair coloring products (Ambrosone et al., 2007) , indicating hair dye is an exposure source of 4-ABP. Chemical hair straighteners can contain formaldehyde or formaldehyde-releasing ingredients; formaldehyde is a known human carcinogen, based on nasopharyngeal cancer and leukemia (IARC 2012a).
Epidemiological studies.
Three studies analyzed self-reported hair dye use and breast cancer. A Finnish case-control study reported a significantly higher risk for ever use, cumulative number of hair dye episodes, and first use before age 30 (Heikkinen et al., 2015) , while the Shanghai Women's Health Study found no association for hair dye use or duration of use in the previous three years (Mendelsohn et al., 2009 ). While the case-control study could be subject to recall bias, the Shanghai study problematically classified women who had not used hair dye within the past three years as "never users," even though breast cancer may originate from much earlier exposures. In fact, the Finnish study showed increased risk for women who first used hair dye at ages 20-29 but not 40 and older. Types (temporary, permanent, bleach) and colors of dyes likely are different between these study populations. The Black Women's Health Study did not find any significant associations with chemical hair straighteners, considering frequency or duration of use and age at first use (Rosenberg et al., 2007) .
Per-and polyfluoroalkyl substances (PFASs)
PFASs include hundreds of chemicals with highly fluorinated carbon chains. They have many commercial applications because of their nonstick and stain-resistant properties. The general population is exposed through food contamination, food contact materials, consumer products, and contaminated drinking water. Occupational exposure is likely in firefighting, textile production, and food processing. Longer carbon chain PFASs, such as C8, or perfluorooctanoic acid (PFOA), have been common, but with manufacturer phase-outs (U.S. EPA, 2009), the use of shorter-chain PFASs is increasing. Many PFASs are persistent and water soluble and so have emerged as important drinking water contaminants in many communities (Hu et al., 2016) .
3.4.5.1. Biological evidence. PFOA and perfluorooctanesulfonic acid (PFOS) are two of the most researched PFASs in terms of toxicity and exposure; research is ongoing to understand the toxicity of newer PFASs. PFOA is persistent in the body, partitioning to the liver and blood. No metabolic transformations occur, and the half-life in humans is estimated to be 3-4 years (Olsen et al., 2007) . Epidemiological studies from the C8 Science Panel found that PFOA is associated with kidney and testicular cancers (Barry et al., 2013) and decreased immune response (Looker et al., 2014) , and animal studies indicate that PFOA causes liver and kidney toxicity (Wolf et al., 2012) , immunotoxicity (Yang et al., 2002) , effects on the developing mammary gland (White et al., 2007; Yang et al., 2009) , and male reproductive toxicity (York et al., 2010) . Effects on the developing mammary gland were observed at lower doses than other effects (New Jersey DWQI Health Effects Subcommittee, 2016; U.S. EPA 2016a), and one rodent cancer study showed equivocal evidence of increased mammary gland tumors (Sibinski, 1987) . While PFOA binds with the peroxisome proliferator-activated receptor-alpha (PPARα) and other receptors, including ERα (reviewed by Peters and Gonzalez, 2011) , the modes of action leading to adverse effects are not entirely understood (New Jersey DWQI Health Effects Subcommittee, 2016).
Although there is limited evidence of mammary gland effects associated with PFOS, one study with adult rats found significantly increased benign mammary tumors with low doses of PFOS in diet, but a significant decrease in the high dose group (European Food Safety Authority, 2008).
3.4.5.2. Epidemiological studies. Four studies reported on PFASs, with one capturing a critical window of exposure. Bonefeld-Jorgensen et al. (2014) did not find a significant association for PFOA measured in blood samples collected during early pregnancy and breast cancer 10-15 years later in the Danish National Birth Cohort, but mean age of the women at enrollment was under 30, so they were still young at follow up. These authors note significantly elevated odds of breast cancer among the women in the highest compared to the lowest quintile of PFOSA, which breaks down in the body to PFOS, with no evidence of dose-response. Because PFOA alters developing mammary glands, it would be informative to follow the daughters from these pregnancies for breast outcomes. In another study, Bonefeld-Jorgensen et al. (2011) reported significantly higher blood levels of PFOS and PFOA among 31 cases compared to controls among Inuit women in Greenland, as well as a non-significant 20% increase in the odds of breast cancer for every one ng/ml increase of PFOA (based on 7 cases). As previously noted (Section 3.1.4), this population is highly exposed to a number of chemicals (e.g. PCBs, OC pesticides), making it difficult to attribute risk to individual compounds (Bonefeld-Jorgensen et al., 2011) . A follow-up study by Ghisari et al. (2014) examined PFASs and certain polymorphisms in CYP and COMT genes, though the analysis did not control for confounding by breast cancer risk factors (See Table S8 ). In the only study of occupational exposure, a study funded by 3M, Raleigh et al. (2014) evaluated breast cancer risk in relation to modeled ammonium perfluorooctanoate (APFO) concentrations in air at two 3M plants, but did not control for breast cancer risk factors or specify whether estimates were among male or female workers (See Table S8 ).
Flame retardants
Flame retardants include diverse chemicals used in consumer products, including textiles, furniture, insulation, and plastics (Dodson et al., 2012b) . People are primarily exposed through dust or direct contact, as these chemicals are often not bound to their substrate and migrate into air and dust (Lorber, 2008) . Use patterns have changed over time as some flame retardants, such as polybrominated diphenyl ethers (PBDEs) and tris(2,3-dibromopropyl) phosphate (TDBPP), were phased out or banned while others have come into use as substitutes (Dodson et al., 2012b) .
3.4.6.1. Biological evidence. Flame retardants TDBPP and 2,2-bis (bromomethyl)-1,3-propanediol (BBMP) produce mammary tumors in animal studies (NTP, 2016b). However, based on the Chemical Carcinogenesis Research Information System database (Tonxnet, K.M. Rodgers et al. Environmental Research 160 (2018) 152-182 2016), PBDEs appear not to have been tested for carcinogenicity in rodents. PBDE mixtures have also increased cell proliferation in estrogen-sensitive breast cancer cells (Li et al., 2012; MercadoFeliciano and Bigsby, 2008) , and a study that exposed rats to a commercial mixture of PBDEs, during and after gestation, showed changes in mammary gland development (Kodavanti et al., 2010) , indicating they act via multiple pathways.
3.4.6.2. Epidemiological studies. We identified three studies of flame retardant exposure and breast cancer. Hurley et al. (2011) found no association between California women's adipose levels of PBDEs and breast cancer, while Holmes et al. (2014) reported non-significantly increased risk with BDE-47 blood levels in Alaskan Native women. Terrell et al. (2016) observed nearly-significantly elevated odds of breast cancer (OR 2.60, 95% CI: 0.93-7.27; based on 9 cases) among women with higher blood levels of polybrominated biphenyl (PBB) measured 30+ years prior, following contamination of the food supply. PBB flame retardants are structurally similar to PCBs and are thought to exert toxicity in similar ways (Lauby-Secretan et al., 2013) .
Drinking water
Drinking water is often contaminated with domestic wastewater, fertilizer, other agricultural chemicals (Sections 3.1.3 and 3.2), and industrial contaminants (Sections 3.1.1, 3.1.2 and 3.6) from local land uses and discharges. Domestic wastewater (sewage) is a source of consumer product chemicals, pharmaceuticals, and excreted natural hormones (Section 3.4).
Epidemiological studies
Here we review four studies of drinking water that measure wastewater contamination or a proxy; two studies of solvent-contaminated drinking water are reviewed in Section 3.6. On Cape Cod, MA, Brody et al. (2006) did not find an association for estimated historical nitrate-N, a marker of wastewater contamination, but the authors note the analysis was limited by reliance on average concentrations across multiple water sources in each district. On the other hand, Gallagher et al. (2010) reported marginally elevated odds of breast cancer among women ever exposed to drinking water contaminated with wastewater, based on a model of contamination from the Barnstable (Cape Cod) Water Pollution Control Facility. Of note, some of the drinking water wells were also contaminated by VOCs from a local airport or surrounding septic systems (Schaider et al., 2010) .
The Iowa Women's Health Study and the Multicase-control Study in Spain did not find any significant associations between nitrate in drinking water and breast cancer (Espejo-Herrera et al., 2015; InoueChoi et al., 2015) . However, the Iowa study found a significant positive association between higher versus lower nitrate levels among women with adequate folate intake, which the authors hypothesize could be related to tumor promoting actions of folate (Inoue-Choi et al., 2015) . There was no evidence of an interaction with folate in the Spain study (Espejo-Herrera et al., 2015) , where the estimated nitrate and folate intake were both lower than in Iowa.
Disinfection byproducts and other contaminants of drinking water remain understudied.
Organic solvents
Among 30 organic solvents known to cause mammary gland tumors in animal studies , benzene, alcohol, and methylene chloride are well studied and may inform hypotheses about some other solvents. Occupational use is a primary source of exposure for methylene chloride and, historically and outside the U.S., for benzene. Occupations with solvent exposure include dry cleaning, electronics manufacturing, leather and fur processing, and metal, auto, textile, and some military work (Peplonska et al., 2010) . Major additional sources of benzene include gasoline, vehicle exhaust, and tobacco smoke . • IARC carcinogen (IARC, 2010b) • Alcohol (ingested) increases ER+ tumors, and consumption before first childbirth increases risk (Y Liu et al., 2015) .
• Alcohol consumption increases blood estrogen (Frydenberg et al., 2015; IARC, 2010b) • IARC carcinogen (IARC, 2012c) • Benzene produces increased mammary carcinomas in many animal studies (IARC, 2012c) • IARC possible human carcinogen (IARC, 1999) • Inhaled methylene chloride is associated with benign mammary tumors in rats (IARC, 1999; NTP, 1986) • 5 structurally similar halogenated organic solvents also induce rodent mammary tumors Hypothesized modes of action When ingested:
• ROS formation from oxidative metabolism by CYP2E1 (IARC, 2012c)
• CYP2E1 polymorphisms modify relationship between air benzene and blood micronuclei-a measure of genotoxicity (Zhang et al., 2014 ).
• Possible non-classical interaction with
AhR (Badham and Winn, 2007) • DNA damage via GST metabolism (Bruhn et al., 1998; Hallier et al., 1994) • The GST pathway forms formaldehyde, is associated with DNA damage, and is influenced by polymorphisms in GSTT1 genes (Bruhn et al., 1998; Hallier et al., 1994 ).
• CYP2E1 secondary metabolic pathway (EU, 2012; U.S. EPA, 2011)
• Genotoxicity from major metabolite, acetaldehyde, and DNA adduct formation (Y Liu et al., 2015) • ROS formation from oxidative metabolism by CYP2E1 (Y Liu et al., 2015) • Increased estrogen, possibly due to effects on hormone homeostasis, resulting in tumor promotion (Al-Sader et al,. 2009) • Altered mammary gland development in rats before first pregnancy (Y Liu et al., 2015) • Altered methylation patterns linked to folate deficiency from chronic alcohol use (IARC, 2010b; Y Liu et al., 2015; Seitz et al., 2012) ROS = reactive oxygen species, IARC= International Agency for Research on Cancer, AhR = aryl hydrocarbon receptor Rodgers et al. Environmental Research 160 (2018) 152-182 3.6.1. Biological evidence IARC classifies benzene (IARC 2012c) and ingested alcohol (IARC 2010b) as carcinogenic to humans, and methylene chloride as possibly carcinogenic based on sufficient animal evidence and some evidence of breast cancer (IARC, 1999) . The classification for alcohol is based on human evidence of breast, liver, and other cancers. Benzene has not been extensively studied in women and the IARC classification is based on leukemia, but the IOM described the association with breast cancer as suggestive (IOM, 2012) .
All three solvents are rapidly cleared and are metabolized by the P450 enzymes, particularly CYP2E1 (IARC 2010b). While many CYPs are involved in hormone regulation, including CYPs induced by PAHs and dioxins, CYP2E1 does not have a recognized role in hormone homeostasis. Differences in structure and biologic activity among these solvents lead to differences in metabolism and potential carcinogenic mechanisms, and there are important data gaps related to endocrine effects, including on the mammary gland. The route of exposure can also influence tumorigenicity, because first pass metabolism in the liver may make chemicals more or less harmful, and inhaled chemicals can bypass the liver, entering the bloodstream directly. In animals, inhaled methylene chloride results in lung and liver cancers and benign mammary tumors, while oral exposure studies are inconclusive (IARC 1999) . Epidemiologic studies generally measure ingested alcohol, while methylene chloride and benzene are usually inhaled. The hypothesized breast cancer mechanisms for each of the three solvents are summarized in Table 4 .
Overall, solvents may act throughout the life course to create genetic damage by the activity of their metabolites. Although mechanistic studies of solvents have not focused on the breast, we anticipate that these pathways are likely to be active in the breast as well.
Epidemiological studies
Since 2006, epidemiological studies added to earlier evidence of an association between organic solvents and breast cancer when exposure was earlier in life and/or of longer duration . Most studies of solvents -other than alcohol consumption -investigated mixtures in occupational settings assessed from detailed interviews (Table S10) .
Several studies reported increased risk of breast cancer with solvent exposure in the early reproductive years. The Sister Study found a significant positive trend in breast cancer risk with increasing duration of solvent work before first childbirth (p = 0.04) and an increased risk of ER+ tumors among women ever vs never exposed during this window (HR, 1.39; 95% CI: 1.03-1.86) (Ekenga et al., 2014) . Studies that examined "ever" exposure to solvents before first childbirth (Glass et al., 2015) or duration of exposure before age 36 ) also reported suggestive positive findings, and Labreche et al. (2010) found a significant association between exposure before age 36 and ER+/PR-tumors. Overall, ever/never solvent use was only weakly associated with breast cancer in the Sister Study (OR, 1.1; 95% CI: 0.9-1.3) (Ekenga et al., 2015a) , highlighting the importance of considering timing and duration of exposure, and tumor subtypes.
Changing regulations created distinctive exposure scenarios in some studies. Sung et al. (2007) reported that female workers in a solventcontaminated Taiwan electronics factory had an elevated rate of breast cancer compared to the general population (SIR, 1.68; 95% CI: 1.11-2.42). Though the study is limited by lack of formal control for breast cancer risk factors, it provides a unique natural experiment; risk was significantly elevated among women employed before June 20, 1974, when solvent use became regulated, but not among those employed after the regulation. Based on factory records, the authors believe that trichloroethylene (TCE) was the main solvent affected by the 1974 regulation (Sung et al., 2007) . Similarly, in the U.S., the Sister Study observed elevated ER+ breast cancer risk (HR, 1.28; 95% CI: 1.01 -1.62) among women who first worked at a job with solvent exposure before 1980 and no association for later years, which could reflect the impact of regulatory change in the 1970s (Ekenga et al., 2014 ).
In addition to the findings for ER+ tumors and exposure in early adulthood described above, Glass et al. (2015) found higher odds of ER + tumors considering self-reported 'ever vs never' occupational exposure to solvents in Australia. Conversely, in a Polish population-based study, Peplonska et al. (2010) reported a significant association between > 10 years solvent exposure and ER-/PR-tumors but not other subtypes, suggesting a mechanism other than hormonal tumor promotion. Analyses stratified by menopausal status showed a significant trend in risk of breast cancer diagnosis with increasing duration of exposure to organic solvents among premenopausal (p = 0.026) but not postmenopausal women in the Polish study (Peplonska et al., 2010) , and non-significantly elevated ORs for benzene, aromatic solvents, aliphatic compounds and chlorinated solvents among premenopausal women in the Australia study (Glass et al., 2015) .
Other investigations of occupational exposure to specific solventsbenzene, TCE, methylene chloride -tended to be limited by (1) the use of breast cancer mortality as an indicator of disease, which is not a sensitive measure of incidence given high survival rates for some breast cancer sub-types; (2) lack of control for confounding; and (3) using the general population as a comparison group (See Table S10 ). The exception was a study by Oddone et al. (2014) , which limited the analysis of TCE exposure in an Italian electrical manufacturing cohort to blue collar workers, and found elevated odds of breast cancer among women who ever worked with TCE (OR among women who worked at the factory for 10+ years, 2.10; 95% CI: 1.21, 3.66).
Two studies evaluated solvents in drinking water, which includes ingestion, dermal contact, and inhalation exposure pathways. Gallagher et al. (2011) updated previous exposure estimates (Aschengrau et al., 1998 ) from tetrachloroethylene-contaminated drinking water on Cape Cod, MA, with an improved water flow model, and again observed elevated risk among women with high tetrachloroethylene (PCE) exposure (OR, 1.3; 95% CI: 0.9-1.9). Ruckart et al. (2015) reported a nonsignificant elevated risk of breast cancer among male Marines ever stationed at Camp Lejeune during a period when water serving the base was contaminated with TCE, PCE, vinyl chloride, and benzene. Suggestive positive associations were found for high cumulative exposure to PCE, 1,2 dichloroethylene (DCE), and vinyl chloride. The PCE finding is limited by the small number of highly-exposed participants (n, 10).
Four of the studies of occupational solvents considered alcohol consumption because of recognized interactions between these exposures, especially via CYP2E1. Among women ever exposed to any organic solvents or to benzene specifically, Peplonska et al. (2010) found no significant difference in ORs in women who had ever versus never consumed alcohol. Two studies adjusted for alcohol consumption Oddone et al., 2014) , while Glass et al. (2015) found no difference in the effect estimate for solvent exposure when controlling for alcohol consumption so did not include it in the final model.
Occupation
Job histories in combination with exposure matrices that link jobs to chemicals can be used to reconstruct occupational exposures to some chemicals or mixtures. Job titles are often used as proxies for exposure to all of the chemicals in a particular workplace; this helps address concerns about studying individual chemicals independently when we know that exposures are often concurrent . Table 5 includes toxicologically relevant information about five chemicals or chemical groups (ethylene oxide, styrene, 1,3-butadiene, aromatic amines, acrylamide) with occupational exposures that we have not yet discussed. We also report on occupations with potential exposures to chemicals previously discussed in this review.
Epidemiological studies
Most studies of job titles and breast cancer in the last 10 years addressed some earlier methodological concerns: New studies controlled K.M. Rodgers et al. Environmental Research 160 (2018) 152-182 for confounding by reproductive risk factors, collected job histories from participants rather than employment records, and focused on incidence rather than mortality, which is not a sensitive indicator of disease risk . However, low statistical power due to small numbers of women in particular job sectors remains an important limitation. In addition, variation in job title coding limits comparisons of consistency across broad job surveys (defined here as studies analyzing > 10 job categories/industries). In studies with comparisons to the general population, true associations between jobs and breast cancer may be underestimated as a result of the healthy worker effect. Here we report on ten studies of occupational exposure to chemicals not previously discussed, and ten job title studies, most of which were broad surveys. Seven studies did not meet our criteria for discussion (Table S11) .
3.7.1.1. Work with ethylene oxide. A retrospective study in a cohort of Swedish sterilant workers at medical equipment plants indicated a possible dose response with ethylene oxide (EtO) and breast cancer: women with medium exposure had an elevated IRR of 2.76 (95% CI 1.20-6.33), and women with the highest cumulative exposure had an IRR of 3.55 (95% CI 1.58-7.93), compared to women with lowest cumulative exposure (Mikoczy et al., 2011) . In a broad job survey, Peplonska et al. (2007) reported null results for ever versus never exposure to EtO (OR, 0.9; 95% CI: 0.6-1.4). Several investigators reported associations between breast cancer and work in healthcare, where potential exposures include ethylene oxide, solvents, therapeutic agents, shift work, and ionizing radiation. Studies observed positive associations for female nurses (Kjaer and Hansen, 2009; Santi et al., 2015; Villeneuve et al., 2011) , medical and health care workers (Ji et al., 2008) , and among males in health and social work (8 exposed cases) (Villeneuve et al., 2010) . Peplonska et al. (2007) also found higher odds of breast cancer for female nurses in specialty hospitals (OR = 2.2; 95% CI: 1.1 -4.6) but not for registered nurses overall.
3.7.1.2. Work with styrene and 1,3-butadiene. Only one study measured occupational exposure to styrene and butadiene; other studies in the rubber industry used job titles or estimated exposure to other agents. In a cohort of eight North American rubber manufacturing plants, women with the highest cumulative exposures to styrene and to butadiene had elevated breast cancer mortality (OR for 1,3 butadiene, 1.9; 95% CI: 0.8-4.4; OR for styrene, 1.5; 95% CI: 0.6-3.4; both based on 9 breast cancer deaths in the high exposed group) compared to women with no exposure (Sathiakumar and Delzell, 2009 ). Because styrene and 1,3 butadiene are correlated in this industry, the authors did not attempt to model independent effects of these chemicals. The lack of control for breast cancer risk factors is a concern for this analysis because the comparison group is the general population. Additional evidence for the rubber industry included a significant trend in breast cancer mortality across quartiles of cumulative exposure to aromatic amines in a rubber tire manufacturing plant, based on 11 breast cancer deaths (de Vocht et al., 2008) . Findings across job title studies were generally positive but not significant, with elevated odds for work in the manufacture of plastic and rubber products, (Ji et al., 2008; Villeneuve et al., 2011) , including in a male cohort (6 exposed cases) (Villeneuve et al., 2010) . • GP: low levels through contact with sterilized products, including medical products, cosmetics, tobacco smoke, and food (NTP, 2016b) • IARC and NTP carcinogen based on evidence of lymphatic tumors in humans, mixed evidence of hematopoietic and breast cancer in humans, and evidence of mammary gland tumors in animals following inhalation (IARC, 2008; NTP, 2016b) • Direct alkylating agent, forms DNA and hemoglobin adducts in animals and is genotoxic and mutagenic
• In humans, EtO produced from endogenous ethylene forms DNA adducts, but evidence for DNA adduct formation from exogenous EtO exposure is weak (IARC, 2008) • Primarily eliminated via hydrolysis to ethylene glycol; further metabolism of ethylene glycol may produce another agent, glycoaldehyde, with DNA-damaging potential
• GST is the secondary metabolic pathway (IARC, 2008)
Styrene
• Occ: Work in plastics and synthetic rubber production as well as work with styrene-containing products such as paints and adhesives (IARC, 2002; NTP, 2016b) • GP: Cigarettes, vehicle exhaust, building materials and consumer products (NTP, 2016b) • IARC human carcinogen with mixed findings for mammary tumors in animals (IARC, 2002) • Genotoxic actions may be driven by DNA adduct formation by its primary metabolite, styrene-7,8-oxide via CYP2E1 metabolism (IARC, 2002 ; NTP, 2016b) 1,3-Butadiene
• Occ: Work in petroleum refining, manufacture of rubber and plastic products (IARC, 2012; NTP, 2016b) • GP: Gasoline, vehicle exhaust, cigarettes, heating of certain cooking oils (e.g. canola oil) (NTP, 2016b) • IARC and NTP carcinogen based on haematolymphatic malignancies in humans with evidence for mammary tumors (malignant and benign) in animals following inhalation (IARC, 2012a; NTP, 2016b) • Metabolism by CYP2E1, GST and EH-catalyzed hydrolysis pathways involves formation of epoxide intermediates -epoxybutene, diepoxybutane and epoxybutanediol -that are genotoxic and can form DNA adducts (IARC, 2012a; NTP, 2016b) Aromatic amines
• Occ: Used in production of food packaging, dyes, rubber, inks, textiles, paints, uncured polyurethane foam, spray-in insulation, sealants and coatings (NLM, 2017; NTP, 2016b) • GP: paints, hair and textile dyes, breast implants, tobacco smoke (NTP, 2016b) • 15 aromatic amines produce mammary gland tumors in rodent cancer bioassays 
Acrylamide
• Occ: Work in paper making, wastewater treatment, & production of permanent press fabrics (NTP, 2016b)
• GP: Food packaging (paper and adhesives), heating of starchy foods, tobacco smoke, wastewater treatment byproducts, and some consumer products (NTP, 2016b) • IARC possible human carcinogen based on DNA damage in humans and animals and genetic mutations in animals (IARC, 1994) • Produces mammary tumors in female rats with chronic oral exposure • Partially metabolized via cytochrome P450 to produce glycidamide, a mutagenic metabolite. Glycidamide forms DNA adducts and glycidamide and acrylamide both form hemoglobin adducts, leading to genotoxic action (IARC, 1994) Occ = occupational exposure, GP = general population exposure, IARC = International Agency for Research on Cancer, NTP = National Toxicology Program, EtO = ethylene oxide, GST = Glutathione S-transferase, EH = epoxide hydrolase Chemicals included in this table were not reviewed prior to Section 3.7 and have relevant occupational exposures.
K.M. Rodgers et al. Environmental Research 160 (2018) 152-182 However, one study found no increased risk for rubber and plastics manufacturing work (Peplonska et al., 2007) .
3.7.1.3. Work with aromatic amines. A population based case-control study in Germany assessed exposure to aromatic and heterocyclic amines from self-reported work with film development, the rubber industry, hair dyes, leather, textiles, paper, painting, and tar (Rabstein et al., 2010) . The study found non-significant positive associations for ER+ and PR+ breast cancers. This also adds to the evidence of increased breast cancer mortality with aromatic amine exposure in rubber manufacturing (Section 3.7.1.2).
3.7.1.4. Work with acrylamide and other acrylamide exposure. A few studies had positive findings for acrylamide. One study of job titles observed significantly higher odds of breast cancer in the paper industry, which is a source of acrylamide exposure (Oddone et al., 2013) . In the prospective, population-based Danish Diet Cancer and Health study, increasing levels of acrylamide-hemoglobin (AA-Hb) adducts in blood measured in postmenopausal women 0-7 years before diagnosis were associated with increased risk of ER+ breast cancer, with a suggestion of higher risk among smokers (Olesen et al., 2008) , and with worse survival among non-smokers with ER+ breast cancer (Olsen et al., 2012) . However, hemoglobin adducts represent recent exposure and are not source-specific. Adduct levels measured in workers, mostly men, in acrylamide manufacturing (up to 34,000 pmol/g) or work with grout (up to 17,000 pmol/g) (NTP, 2016b) are much higher than those reported in the Danish study (95th percentile for non-smokers: 137 pmol/g, for smokers: 389 pmol/ g) (Olsen et al., 2012) , so studying acrylamide in female workers could be more informative than in a general population.
3.7.1.5. Work in various industries. Among broad job surveys, Brophy et al.'s (2012) large, population-based case control study in Ontario, Canada, employed the most comprehensive exposure assessment, including consideration of biological features relevant to breast cancer. Specifically, the authors analyzed breast cancer in relation to estimated exposure (high, medium, or low) in particular job sectors and in sub-analyses stratified by windows of susceptibility, menopausal status, and tumor subtypes. Analysis of eight "major" job sectors showed significantly higher odds of breast cancer for women working at least 10 years in high-exposure jobs in farming (OR, 1.34; 95% CI: 1.03-1.74), plastics (OR, 2.43; 95% CI: 1.39-4.22), and metalworking (OR, 1.73, 95% CI: 1.02-2.92). Additional support for risk associated with farming came from studies that found significant positive associations for work in agriculture, as well as work in healthcare or auto manufacturing following previous work in agriculture (Brophy et al., 2006) ; work on a cotton plantation (4 exposed cases), and as a technician in agriculture, engineering, and forestry (Ji et al., 2008) ; and, among men, work in forestry or logging (7 exposed cases) (Villeneuve et al., 2010) . Studies that included jobs or agents related to metalworking found significant positive associations for work with soldering material (Ekenga et al., 2015a) , work as welders, pipeline workers, and metal installers (7 exposed cases) (Ji et al., 2008) . No increase in breast cancer mortality was found for an internal comparison of work with oil-based or water-based metal working fluids (Friesen et al., 2012) . These findings add to earlier evidence for increased breast cancer risk for farming occupations and for exposure to metalworking fluids, cited in our previous review . Considering more specific "minor" job sectors, Brophy et al. (2012) reported higher odds of breast cancer for women working at least 10 years in high-exposure jobs in the canning industry, which the authors state is associated with BPA inhalation. Ji et al. (2008) also found a significant positive association with canning, pickling, and preserved food workers (4 exposed cases) in the Shanghai Women's Health Study. Brophy et al. (2012) found increased breast cancer odds with plasticsrelated work in the auto industry, and in small enterprise auto industry.
Other findings relevant to work in the auto industry included significantly higher odds of breast cancer among men ever employed as motor vehicle mechanics and in sale and repair of motor vehicles (Villeneuve et al., 2010) and significantly elevated risk with more than 10 years in motor vehicle and trailer manufacturing (Villeneuve et al., 2011) . Work in the auto industry has many possible exposures, including gasoline and petroleum products, which could involve benzene, PAHs, and air pollutants, for which we have already discussed mechanistic hypotheses (See Section 3.6 and Section 3.3). The Sister Study found a positive association for breast cancer with high compared to low exposure to gasoline or other petroleum products (OR = 2.5; 95% CI: 1.1-5.9) (Ekenga et al., 2015a) . Brophy et al.'s (2012) additional analyses by time period of exposure suggested that associations for plastics work in the auto industry, metalworking, and canning were stronger for cumulative exposure during the window between menarche and first pregnancy than in subsequent periods. The odds ratio during this period was significant only for plastics workers, and a test of trend across time periods was not reported. Additional analyses suggested that the associations might be specific to tumor sub-type (canning: ER+/PR-and ER-tumors; metalworking: ER+/PR+ tumors; plastics: ER+/PR+ tumors; farming: ER-tumors), though confidence intervals were wide. Odds ratios for canning and plastics appeared to be higher among premenopausal than postmenopausal women.
Several studies considered exposures in the textile industry, including solvents, dyes, stain-resistant treatments and flame retardant chemicals (Liu et al., 2014; Singh and Chadha, 2016) . Studies that quantified occupational exposure found significantly or nearly significantly elevated odds of breast cancer for high exposure to dyes and inks (Ekenga et al., 2015a) ; lifetime exposure to inks, and exposure to inks before age 36 ; lifetime exposure to acrylic and rayon fibers ; exposure before age 36 to wool and nylon fibers ; initiation of work in tailoring and sewing > 20 years before diagnosis (9 exposed cases) (Ji et al., 2008) ; and for less than 10 years of exposure to wool fibers, 10-20 years of exposure to mixed fibers, and 10-20 years of cutting and sewing work (Ray et al., 2007) . Conversely, when Ray et al. (2007) estimated exposure to cotton dust in a cohort of textile workers in Shanghai, they observed a protective effect, particularly when allowing for a 20 year lag. They also reported a protective association with endotoxin, a bacterial contaminant of cotton dust, and hypothesized that their findings could reflect endotoxin's induction of an inflammatory response that may inhibit proliferation of cancer cells. Across broad surveys, statistically significant positive associations included work in the textile industry (Oddone et al., 2013; Shaham et al., 2006) and among textile, apparel, and furnishing machine operators and tenders and hand sewing occupations (Peplonska et al., 2007) . Two studies reported non-significant positive associations for spinning and weaving (Peplonska et al., 2007; Villeneuve et al., 2011) .
Several occupations involving chemicals relevant to breast cancer had statistically significant positive findings in just one study; while these could be chance findings, they give some information about possibly promising areas for future study. Such hypothesis-generating findings included elevated breast cancer odds ratios for male painters (7 exposed cases) and furniture manufacturers (9 exposed cases) (Villeneuve et al., 2010) ; for women ever employed in non-metallic mineral manufacturing or chemical manufacturing (Villeneuve et al., 2011) ; printing machine operators and tenders (Peplonska et al., 2007) ; and electrical manufacturing (Oddone et al., 2014) . A study of career firefighters by Daniels et al. (2014) did not meet our inclusion criteria for this review because these authors did not control for confounding in their comparison to the general population (see Table 1 ); however, their finding of increased breast cancer incidence and mortality among career female firefighters should be a focus of further study given the many breast cancer-relevant exposures, including PAHs, combustion byproducts, flame retardants and PFASs.
Conclusion
Strength of epidemiologic evidence
New epidemiological studies add to evidence that EDCs and chemicals that are mammary carcinogens in animal models influence the risk of breast cancer. Increased breast cancer risk was observed in key studies of exposure during breast development to PAHs and air pollution, DDT, dioxins and PFOSA, and occupational exposure to solvents and other agents. Contributions in the past decade include the development and maturation of several cohorts with prospective assessment of exposures during relevant windows of susceptibility, assessment of individual-level residential and occupational histories related to exposure, and, in two studies, the use of a functional assay for estrogenicity to account for chemical mixtures.
Four notable studies -three focused on exposure in early life and one that uses a functional assay -provide evidence that exposure to persistent EDCs is associated with breast cancer. 1) The CHDS linked exposures to constituents of DDT and PCBs to later breast cancer outcomes in two generations (Cohn et al., 2007 (Cohn et al., , 2012 (Cohn et al., , 2015 . 2) The Danish National Birth Cohort (DNBC) reported that higher blood PFOSA during early pregnancy was significantly associated with breast cancer before age 40 . 3) Women who were under 40 years old at the time of the 1976 Seveso dioxin explosion and had higher blood levels of TCDD had significantly higher breast cancer risk after 11-20 years of follow up (Warner et al., 2011) . 4) Increased breast cancer risk was observed with increasing levels of xenoestrogen burden in serum at diagnosis, measured as estrogenic activity in cell culture (Pastor-Barriuso et al., 2016) .
Among LIBCSP women, genetic variants appear to modify the association between PAH-DNA adduct levels and breast cancer, particularly genes associated with DNA repair and apoptotic signaling. To evaluate the reproducibility and relevance of these observations, the EPIC cohort and other cohorts with archived biological samples could measure PAH-specific (rather than bulky) DNA adducts and consider effect modification by genetic variants, as well as menopausal status and tumor sub-types.
Case-control studies of modeled traffic-related or occupational exposure to air pollution provide evidence of increased risk, including studies that considered early life exposures and menopausal status. However, findings were mostly null in several prospective cohorts, possibly because they used different methods to estimate air pollution, or because they did not evaluate early life exposure or menopausal status.
Since our 2007 review, the strength of evidence increased for higher breast cancer risk from solvents, particularly from exposure in younger women and for longer periods of time. Future studies of solvents -and other agents that are metabolized by CYP2E1 -should consider effect modification from alcohol consumption, as well as CYP, and, when relevant, GST gene variants. Evaluating whether endogenous estrogen levels are affected by solvent exposure could also help elucidate mechanisms.
In occupational studies, associations with breast cancer were observed for many specific agents and for job classifications that involve exposure to mammary carcinogens or EDCs. Elevated risks were seen with exposure to aromatic amines (de Vocht et al., 2008) , ethylene oxide (Mikoczy et al., 2011) , dyes/inks (Ekenga et al., 2015a) and petroleum/gasoline (Ekenga et al., 2015a; Labreche et al., 2010; Rai et al., 2016) . Additionally, exposures before age 36 to solvents, textiles, and inks were associated with postmenopausal breast cancer . Higher risk occupations with plausible mammary carcinogen or EDC exposure included: farming (Brophy et al., 2006 (Brophy et al., , 2012 Ji et al., 2008) , plastics (Brophy et al., 2012) , metal work (Brophy et al., 2012) , automotive work (Brophy et al., 2012; Villeneuve et al., 2010 Villeneuve et al., , 2011 (Villeneuve et al., 2011) and rubber manufacturing (Villeneuve et al., 2010) .
We were unable, however, to draw conclusions about the strength of evidence for tumor promotion from studies of persistent EDCs measured later in life. Despite appropriate control for confounding and adequate exposure measurements, most studies did not distinguish pre-from post-menopausal cancers, and among those that did, differences in the particular measures analyzed (e.g. individual PCB congener vs grouping vs total PCBs) and in the methods used to control for lipids hindered comparison across studies. Similarly, while there is animal evidence of mammary gland developmental disruption for several current use pesticides and consumer product chemicals, few of the epidemiologic studies we reviewed were both free of serious methodologic limitations and designed to capture a relevant window of exposure. It will be informative to follow the DNBC and Sister Study, which have prospective measures of exposure (biological and self-report, respectively) to consumer product chemicals.
The overall body of evidence is strengthened by the consistency between experimental studies and epidemiology. For example, human studies of dioxin and DDT that had long follow-up and captured exposure during periods of breast development complement animal studies that show alterations in the mammary gland from early exposure to these chemicals. Animal evidence for dioxin also indicates increased susceptibility of the mammary gland to carcinogens after early exposure, but this effect has not been investigated for DDT. PAHs, air pollution, solvents, and additional occupational exposures are both carcinogenic and hormonally active. Based on carcinogenicity, we expect effects of early life exposure and interactions with cell-repair genes, and positive associations consistent with these hypotheses were reported in human studies in the past decade. Predictions based on the hormonal activity of these exposures are less clear, because different chemicals within the mixtures have different mechanistic effects.
Research needs
Research needs include continued support of unique cohorts with prospective exposure measurements from early life; some of these cohorts are young, so further follow-up is likely to be informative. Shorter-term studies that focus on particular windows of susceptibility and use intermediate effect markers such as puberty timing, breast density, lactation, or omics outcomes can help address barriers related to the long latency of breast cancer and provide further insight about underlying breast cancer mechanisms. The NIEHS Breast Cancer and the Environment Research Program is an example of this approach and is strengthened by inclusion of parallel studies in experimental models and humans (NIEHS BCERP). Our review adds confidence that experimental toxicology can guide epidemiologic study design, including the choice of chemicals, exposure biomarkers, windows of susceptibility, and genetic polymorphisms.
We noted several areas for improvement for cohort and other studies. While occupational exposure assessments have improved, more appropriate comparison groups are needed to avoid confounding by differences in baseline risk between exposed and unexposed populations. Further, the lack of consistency in the approach to confounder control and results presentation across studies is a significant barrier to integrating knowledge across studies. Only a few studies, including the Sister Study (Ekenga et al., 2014 (Ekenga et al., , 2015a Niehoff et al., 2016) and LIBCSP (Mordukhovich et al., 2010 (Mordukhovich et al., , 2016a (Mordukhovich et al., , 2016b Parada et al., 2016a Parada et al., , 2016b White et al., 2013 White et al., , 2014 , explicitly used a priori knowledge and hypotheses about underlying causal structures to select confounders to include in models. In contrast, most studies selected confounders based on statistical criteria (e.g. the "10% rule"), which can increase rather than control bias, in either direction (Hernan et al., 2002) . One important example is the consideration of lipids in analyses of chemicals in blood that partition to fat, such as the persistent EDCs.
As reviewed by O'Brien et al. (2017) , simulation studies demonstrate the potential impact of the decision to control for lipids and the choice of method for control; for example, in Schisterman et al.'s (2005) analysis, the commonly employed lipid standardization method was prone to bias under all but one possible causal model. It is thus essential that investigators consider and communicate what they hypothesize to be the underlying model. It would also be helpful if studies that choose to normalize their chemical concentrations to lipid levels present the non-standardized measures as well. A similar issue arises in reports of gene-environment interactions, where different choices for the reference group can hinder comparisons. Knol and VanderWeele (2012) provide excellent advice for standardizing presentation of interaction analyses.
One important barrier to progress is that many exposures are complex mixtures of chemicals that have varied biological activities, for example PCBs and PAHs. Commonly-used summary exposure biomarkers can be difficult to interpret, because variation between study participants can reflect different exposure sources (representing different mixtures), varied time since exposure, and/or individual variation in chemical metabolism. Studies of gene-environment interactions can clarify effects of variation in metabolism. Studies that separate participants with different types of exposures (e.g., tobacco use versus air pollution) allow investigation of more homogenous mixtures and may yield more consistent results. An alternative approach is to use measures that represent a relevant biological activity across multiple chemicals, for example estrogenic activity or DNA damage. Two studies reviewed here were the first to use this approach in blood, measuring estrogenic activity in the non-polar fraction that does not include endogenous estrogens (Bonefeld-Jorgensen et al., 2011; Pastor-Barriuso et al., 2016) . This innovation generates new questions about the interpretation of high or low estrogenic activity in blood, and methods to measure other types of activity are also needed. Indeed, an approach that integrates biologically similar effects in common mixtures is an NIEHS priority (Carlin et al., 2013) . Recent results suggest that some carcinogens, such as ionizing radiation and tobacco smoke, appear to produce a distinctive mutation signature in the tumor that can be discerned with DNA sequencing (Alexandrov et al., 2016; Behjati et al., 2016) , and these signatures may be useful for retrospective exposure assessment or translation from animals to humans.
Challenges in epidemiology also highlight the need for better chemical testing and risk assessment approaches that are relevant to breast cancer, so we can predict increased risks and reduce exposures. Recent papers describing biological characteristics of carcinogens (Smith et al., 2016) and breast carcinogens (Schwarzman et al., 2015) represent important new work in this area. As noted in this review, effects on mammary gland development have been reported as the most sensitive effect in animal studies for PFOA, chlorpyrifos, and atrazine, yet EPA risk assessments did not use these findings because of methodological questions (U. S. EPA 2006c S. EPA , 2014 S. EPA , 2016a Ventura et al., 2016) , raising concern that the EPA assessments are not protective for mammary gland effects. Developing methods to assess effects on mammary gland development is a critical research and policy need (Rudel et al., 2011a; Tucker et al., 2015) .
Public health implications
Because breast cancer is so common and incidence is increasing as countries industrialize worldwide, risks from widespread exposure to environmental chemicals pose an important public health problem, even if the increased individual risks are modest (Bellinger, 2012) . New human evidence supports exposure reduction for air pollutants, organic solvents and other chemicals that are mammary gland carcinogens in animal models. While DDT and PCBs have been mostly phased out and blood levels are falling, the evidence that past exposures during early life contribute to later breast cancers suggests precaution in the use of other chemicals that disrupt mammary gland development in toxicological studies. A precautionary approach is especially important because study methods are limited, short of a 50-year study, to evaluate the life-long risks to humans from these chemicals -including ingredients in current-use consumer products. Epidemiological evidence continues to support the recommendations of the IOM and IBCERCC that developing in vitro and in vivo chemical screening tests is a priority to inform decisions about chemical use (IBCERCC, 2013; IOM, 2012) . The parallels between epidemiological and toxicological evidence also strengthen confidence that experimental evidence can guide public health decisions when human evidence is not available. Further, because replication of epidemiologic findings for environmental chemicals and breast cancer is often not possible, public health decisions should give increased weight to the few studies, such as the CHDS, that have appropriate biological samples, the ability to capture windows for breast development, participant information to control for confounding, and long-term follow up.
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